NPORT-EX 2 JHIAAACLOETF.htm
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
1
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
106
.1
%
1988
CLO
1
Ltd.
2022-1A
AR,
CME
Term
SOFR
3
Month
+
1.3600%,
5.9291%,
10/15/39
(144A)
‡
$
133,000,000
$
133,563,747
1988
CLO
2
Ltd.
2023-2A
A,
CME
Term
SOFR
3
Month
+
2.3200%,
6.6220%,
4/15/38
(144A)
‡
85,835,000
86,276,535
720
East
CLO
Ltd.
2023-2A
A2,
CME
Term
SOFR
3
Month
+
2.1500%,
6.4520%,
10/15/36
(144A)
‡
13,000,000
13,068,861
AB
BSL
CLO
1
Ltd.
2020-1A
A1R,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6720%,
1/15/35
(144A)
‡
25,500,000
25,579,642
AB
BSL
CLO
3
Ltd.
2021-3A
A,
CME
Term
SOFR
3
Month
+
1.4516%,
5.7448%,
10/20/34
(144A)
‡
20,000,000
20,067,216
AGL
CLO
14
Ltd.
2021-14A
A,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7048%,
12/2/34
(144A)
‡
83,390,000
83,537,333
AGL
CLO
16
Ltd.
2021-16A
A,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6848%,
1/20/35
(144A)
‡
31,341,220
31,393,403
AGL
CLO
17
Ltd.
2022-17A
AR,
CME
Term
SOFR
3
Month
+
0.9500%,
0.0000%,
1/21/35
(144A)
†,‡
149,858,000
149,048,767
AGL
CLO
17
Ltd.
2022-17A
A,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6232%,
1/21/35
(144A)
‡
148,858,000
149,096,694
AGL
CLO
20
Ltd.
2022-20A
A2R,
CME
Term
SOFR
3
Month
+
1.5900%,
5.8832%,
10/20/37
(144A)
‡
22,500,000
22,525,081
AGL
CLO
21
Ltd.
2022-21A
A1R,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6532%,
10/21/37
(144A)
‡
89,750,000
90,251,182
AGL
CLO
30
Ltd.
2024-30RA
A1,
CME
Term
SOFR
3
Month
+
1.5300%,
5.8232%,
4/21/37
(144A)
‡
50,000,000
50,349,430
AGL
CLO
34
Ltd.
2024-34A
A1,
CME
Term
SOFR
3
Month
+
1.3400%,
5.7416%,
1/22/38
(144A)
‡
20,000,000
20,116,478
AGL
Core
CLO
2
Ltd.
2019-2A
A1R,
CME
Term
SOFR
3
Month
+
1.4600%,
5.7532%,
7/20/37
(144A)
‡
190,000,000
191,203,080
AGL
Core
CLO
8
Ltd.
2020-8A
A1R2,
CME
Term
SOFR
3
Month
+
1.3300%,
5.7123%,
1/20/38
(144A)
‡
10,000,000
10,079,948
AIMCO
CLO
2018-AA
AR,
CME
Term
SOFR
3
Month
+
1.3100%,
5.8252%,
10/17/37
(144A)
‡
45,000,000
45,226,809
AIMCO
CLO
10
Ltd.
2019-10A
ARR,
CME
Term
SOFR
3
Month
+
1.4100%,
5.7001%,
7/22/37
(144A)
‡
32,100,000
32,294,731
Allegany
Park
CLO
Ltd.
2019-1A
AR,
CME
Term
SOFR
3
Month
+
1.3000%,
5.5901%,
1/20/35
(144A)
‡
27,000,000
27,041,259
Allegro
CLO
VIII-S
Ltd.
2024-3A
A,
CME
Term
SOFR
3
Month
+
1.3900%,
5.9485%,
10/15/37
(144A)
‡
15,200,000
15,228,070
Allegro
CLO
XIV
Ltd.
2021-2A
A2,
CME
Term
SOFR
3
Month
+
1.6116%,
5.9136%,
10/15/34
(144A)
‡
6,875,000
6,893,244
Allegro
CLO
XVIII
Ltd.
2024-4A
A1,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6913%,
1/25/38
(144A)
‡
42,100,000
42,289,450
AMMC
CLO
30
Ltd.
2024-30A
A2,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2520%,
1/15/37
(144A)
‡
8,000,000
8,075,602
Anchorage
Capital
CLO
13
LLC
2019-13A
AR,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6636%,
4/15/34
(144A)
‡
43,955,000
44,088,008
Anchorage
Capital
CLO
18
Ltd.
2021-18A
A1,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7136%,
4/15/34
(144A)
‡
13,100,000
13,142,456
Anchorage
Capital
CLO
19
Ltd.
2021-19A
A,
CME
Term
SOFR
3
Month
+
1.4716%,
5.7736%,
10/15/34
(144A)
‡
27,000,000
27,085,199
Anchorage
Capital
CLO
24
Ltd.
2022-24A
A1R,
CME
Term
SOFR
3
Month
+
1.4300%,
5.7320%,
7/15/37
(144A)
‡
47,000,000
47,386,025
Anchorage
Capital
CLO
24
Ltd.
2022-24A
A2R,
CME
Term
SOFR
3
Month
+
1.6500%,
5.9520%,
7/15/37
(144A)
‡
18,000,000
18,150,491
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
2
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
APEX
CREDIT
CLO
2018-II
Ltd.
2018-2A
BR3,
CME
Term
SOFR
3
Month
+
1.2500%,
0.0000%,
10/20/31
(144A)
†,‡
$
24,400,000
$
24,400,000
APEX
CREDIT
CLO
2018-II
Ltd.
2018-2A
A1RR,
CME
Term
SOFR
3
Month
+
1.2400%,
5.5332%,
10/20/31
(144A)
‡
52,852,023
52,929,710
Apex
Credit
CLO
2024-I
Ltd.
2024-1A
A1,
CME
Term
SOFR
3
Month
+
1.8000%,
6.0932%,
4/20/36
(144A)
‡
15,000,000
15,146,844
Apex
Credit
CLO
2024-II
Ltd.
2024-2A
A,
CME
Term
SOFR
3
Month
+
1.5200%,
5.8201%,
7/25/37
(144A)
‡
49,800,000
50,260,994
Apidos
CLO
L
2024-50A
A1,
CME
Term
SOFR
3
Month
+
1.3400%,
5.7068%,
1/20/38
(144A)
‡
20,000,000
20,159,988
Apidos
CLO
XLVII
Ltd.
2024-47A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
6.0001%,
4/26/37
(144A)
‡
10,000,000
10,093,794
Apidos
CLO
XXIII
2015-23A
AR,
CME
Term
SOFR
3
Month
+
1.4816%,
5.7836%,
4/15/33
(144A)
‡
12,825,000
12,863,971
Apidos
CLO
Xxv
2016-25A
A1R3,
CME
Term
SOFR
3
Month
+
1.1400%,
5.4708%,
1/20/37
(144A)
‡
130,310,000
130,635,775
Apidos
CLO
XXXIII
2020-33A
AR,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7083%,
10/24/34
(144A)
‡
19,630,000
19,663,887
Apidos
CLO
XXXIV
2020-34A
A1R,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7048%,
1/20/35
(144A)
‡
11,400,000
11,419,044
Apidos
CLO
XXXV
2021-35A
A,
CME
Term
SOFR
3
Month
+
1.3116%,
5.6048%,
4/20/34
(144A)
‡
61,279,335
61,375,329
Apidos
CLO
XXXVII
2021-37A
A,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6817%,
10/22/34
(144A)
‡
19,859,000
19,888,788
ARES
L
CLO
Ltd.
2018-50A
AR,
CME
Term
SOFR
3
Month
+
1.3116%,
5.6136%,
1/15/32
(144A)
‡
15,301,624
15,317,203
ARES
LII
CLO
Ltd.
2019-52A
A1R,
CME
Term
SOFR
3
Month
+
1.3116%,
5.6017%,
4/22/31
(144A)
‡
21,141,091
21,141,091
Ares
LIII
CLO
Ltd.
2019-53A
A1R,
CME
Term
SOFR
3
Month
+
1.2800%,
5.5766%,
10/24/36
(144A)
‡
253,955,000
256,043,475
Ares
LIII
CLO
Ltd.
2019-53A
A2R,
CME
Term
SOFR
3
Month
+
1.5000%,
5.7966%,
10/24/36
(144A)
‡
13,000,000
13,080,233
Ares
LIX
CLO
Ltd.
2021-59A
A,
CME
Term
SOFR
3
Month
+
1.2916%,
5.5917%,
4/25/34
(144A)
‡
25,000,000
25,038,530
ARES
Loan
Funding
III
Ltd.
2022-ALF3A
A1R,
CME
Term
SOFR
3
Month
+
1.2700%,
5.5701%,
7/25/36
(144A)
‡
61,875,000
62,068,953
Ares
Loan
Funding
VIII
Ltd.
2024-ALF8
A1,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5429%,
1/24/38
(144A)
‡
119,000,000
119,059,976
Ares
LV
CLO
Ltd.
2020-55A
A1R2,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6720%,
10/15/37
(144A)
‡
39,250,000
39,464,847
Ares
LVI
CLO
Ltd.
2020-56A
A1R2,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5501%,
1/25/38
(144A)
‡
15,000,000
15,075,000
Ares
LVII
CLO
Ltd.
2020-57A
AR,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7117%,
1/25/35
(144A)
‡
15,000,000
15,025,494
Ares
LVIII
CLO
Ltd.
2020-58A
AR,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6320%,
1/15/35
(144A)
‡
25,000,000
25,036,937
Ares
LXI
CLO
Ltd.
2021-61A
A2R,
CME
Term
SOFR
3
Month
+
1.7300%,
6.0232%,
4/20/37
(144A)
‡
19,900,000
20,082,491
Ares
LXIV
CLO
Ltd.
2022-64A
AR,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6620%,
10/24/39
(144A)
‡
42,000,000
42,235,775
Ares
LXIX
CLO
Ltd.
2024-69A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
6.0020%,
4/15/36
(144A)
‡
17,500,000
17,663,338
Ares
LXV
CLO
Ltd.
2022-65A
A2,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0501%,
7/25/34
(144A)
‡
18,000,000
18,050,222
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
3
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Ares
LXVII
CLO
Ltd.
2022-67A
A1R,
CME
Term
SOFR
3
Month
+
1.1900%,
0.0000%,
1/25/38
(144A)
†,‡
$
100,000,000
$
100,035,500
Ares
LXX
CLO
Ltd.
2023-70A
A2,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2501%,
10/25/35
(144A)
‡
24,500,000
24,695,963
Ares
LXXII
CLO
Ltd.
2024-72A
A2,
CME
Term
SOFR
3
Month
+
1.5800%,
5.8820%,
7/15/36
(144A)
‡
24,500,000
24,738,561
Ares
LXXIV
CLO
Ltd.
2024-74A
A2,
CME
Term
SOFR
3
Month
+
1.5500%,
5.8529%,
10/15/36
(144A)
‡
22,500,000
22,698,958
Ares
XLI
CLO
Ltd.
2016-41A
AR2,
CME
Term
SOFR
3
Month
+
1.3316%,
5.6336%,
4/15/34
(144A)
‡
29,720,000
29,764,610
ARES
XLV
CLO
Ltd.
2017-45A
BR,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5520%,
10/15/30
(144A)
‡
5,000,000
5,006,204
ARES
XLV
CLO
Ltd.
2017-45A
CR,
CME
Term
SOFR
3
Month
+
1.5000%,
5.8020%,
10/15/30
(144A)
‡
1,881,250
1,883,969
Ares
XXXIX
CLO
Ltd.
2016-39A
AR3,
CME
Term
SOFR
3
Month
+
1.4200%,
5.7132%,
7/18/37
(144A)
‡
41,500,000
41,739,380
Atlantic
Avenue
Ltd.
2024-2A
A,
CME
Term
SOFR
3
Month
+
1.6500%,
5.9432%,
4/20/37
(144A)
‡
50,000,000
50,627,580
Atrium
XIV
LLC
14A
A2RR,
CME
Term
SOFR
3
Month
+
1.6100%,
5.9176%,
10/16/37
(144A)
‡
35,200,000
35,437,945
Atrium
XV
15A
A2RR,
CME
Term
SOFR
3
Month
+
1.5900%,
5.8976%,
7/16/37
(144A)
‡
47,250,000
47,614,335
Bain
Capital
Credit
CLO
2018-2A
A1R,
CME
Term
SOFR
3
Month
+
1.0800%,
5.3732%,
7/19/31
(144A)
‡
26,674,274
26,689,398
Bain
Capital
Credit
CLO
2019-2A
AR2,
CME
Term
SOFR
3
Month
+
1.1300%,
5.4329%,
10/17/32
(144A)
‡
143,458,338
143,560,208
Bain
Capital
Credit
CLO
Ltd.
2021-1A
A,
CME
Term
SOFR
3
Month
+
1.3216%,
5.6148%,
4/18/34
(144A)
‡
10,000,000
10,031,099
Bain
Capital
Credit
CLO
Ltd.
2022-2A
A1,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6101%,
4/22/35
(144A)
‡
136,890,000
137,327,870
Bain
Capital
Credit
CLO
Ltd.
2020-4A
A1R,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0432%,
10/20/36
(144A)
‡
58,420,000
58,855,241
Bain
Capital
Credit
CLO
Ltd.
2020-4A
A2R,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2432%,
10/20/36
(144A)
‡
20,000,000
20,162,264
Bain
Capital
Credit
CLO
Ltd.
2017-2A
A2R3,
CME
Term
SOFR
3
Month
+
1.6000%,
5.9001%,
7/25/37
(144A)
‡
15,040,000
15,175,856
Balboa
Bay
Loan
Funding
Ltd.
2020-1A
A1RR,
CME
Term
SOFR
3
Month
+
1.2900%,
5.5832%,
10/20/35
(144A)
‡
65,460,000
65,653,762
Balboa
Bay
Loan
Funding
Ltd.
2020-1A
A2RR,
CME
Term
SOFR
3
Month
+
1.6200%,
5.9132%,
10/20/35
(144A)
‡
16,000,000
16,094,109
Ballyrock
CLO
14
Ltd.
2020-14A
A1AR,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6732%,
7/20/37
(144A)
‡
65,400,000
65,940,093
Ballyrock
CLO
19
Ltd.
2022-19A
A1,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6232%,
4/20/35
(144A)
‡
25,000,000
25,078,853
Ballyrock
CLO
25
Ltd.
2023-25A
A1B,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2501%,
1/25/36
(144A)
‡
9,000,000
9,000,000
Ballyrock
CLO
Ltd.
2019-1A
A1R,
CME
Term
SOFR
3
Month
+
1.2916%,
5.5936%,
7/15/32
(144A)
‡
70,502,809
70,561,750
Barings
CLO
Ltd.
2018-4A
A1R,
CME
Term
SOFR
3
Month
+
1.1500%,
5.4520%,
10/15/30
(144A)
‡
72,118,562
72,226,401
Barings
Loan
Partners
CLO
5
Ltd.
LP-5A
A,
CME
Term
SOFR
3
Month
+
1.2200%,
5.5132%,
1/20/35
(144A)
‡
74,219,313
74,350,525
Barings
Loan
Partners
CLO
Ltd.
3
LP-3A
AR2,
CME
Term
SOFR
3
Month
+
0.9500%,
0.0000%,
7/20/33
(144A)
†,‡
100,400,000
100,400,000
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
4
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Barrow
Hanley
CLO
III
Ltd.
2024-3A
A2,
CME
Term
SOFR
3
Month
+
1.8200%,
6.1132%,
4/20/37
(144A)
‡
$
12,000,000
$
12,117,811
Basswood
Park
CLO
Ltd.
2021-1A
A,
CME
Term
SOFR
3
Month
+
1.2616%,
5.5548%,
4/20/34
(144A)
‡
40,100,000
40,131,623
Battalion
CLO
IX
Ltd.
2015-9A
AR,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6636%,
7/15/31
(144A)
‡
43,059,115
43,117,947
Battalion
CLO
XII
Ltd.
2018-12A
A1,
CME
Term
SOFR
3
Month
+
1.3316%,
5.8170%,
5/17/31
(144A)
‡
7,182,764
7,188,417
Battalion
CLO
XV
Ltd.
2020-15A
A2,
CME
Term
SOFR
3
Month
+
1.8616%,
6.1645%,
1/17/33
(144A)
‡
7,500,000
7,517,522
Battalion
CLO
XXI
Ltd.
2021-21A
A,
CME
Term
SOFR
3
Month
+
1.4416%,
5.7436%,
7/15/34
(144A)
‡
14,225,000
14,234,174
Battery
Park
CLO
Ltd.
2019-1A
AR,
CME
Term
SOFR
3
Month
+
1.4000%,
5.7020%,
7/15/36
(144A)
‡
33,180,000
33,354,019
Beechwood
Park
CLO
Ltd.
2019-1A
A1R,
CME
Term
SOFR
3
Month
+
1.3000%,
5.6029%,
1/17/35
(144A)
‡
76,150,000
76,410,631
Beechwood
Park
CLO
Ltd.
2019-1A
A2R,
CME
Term
SOFR
3
Month
+
1.5000%,
5.8029%,
1/17/35
(144A)
‡
10,000,000
10,025,206
Benefit
Street
Partners
CLO
Ltd.
2015-6BR
A,
CME
Term
SOFR
3
Month
+
1.4516%,
5.7448%,
7/20/34
(144A)
‡
24,515,000
24,595,520
Benefit
Street
Partners
CLO
V-B
Ltd.
2018-5BA
A1R,
CME
Term
SOFR
3
Month
+
1.5300%,
5.8232%,
7/20/37
(144A)
‡
60,240,000
60,776,769
Benefit
Street
Partners
CLO
XII-B
Ltd.
2017-12BRA
A,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6720%,
10/15/37
(144A)
‡
100,000,000
100,925,330
Benefit
Street
Partners
CLO
XV
Ltd.
2018-15A
A1R,
CME
Term
SOFR
3
Month
+
1.3900%,
5.6920%,
7/15/37
(144A)
‡
37,500,000
37,805,951
Benefit
Street
Partners
CLO
XXI
Ltd.
2020-21A
A1R,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7336%,
10/15/34
(144A)
‡
25,000,000
25,022,760
Benefit
Street
Partners
CLO
XXI
Ltd.
2020-21A
A2R,
CME
Term
SOFR
3
Month
+
1.6616%,
5.9636%,
10/15/34
(144A)
‡
5,000,000
5,015,999
Benefit
Street
Partners
CLO
XXXII
Ltd.
2023-32A
A2,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2501%,
10/25/36
(144A)
‡
11,000,000
11,104,478
Benefit
Street
Partners
CLO
XXXIII
Ltd.
2023-33A
A2,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2501%,
1/25/36
(144A)
‡
19,375,000
19,552,855
Benefit
Street
Partners
CLO
XXXIV
Ltd.
2024-34A
A2,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0501%,
7/25/37
(144A)
‡
10,000,000
10,079,546
Bethpage
Park
CLO
Ltd.
2021-1A
A,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6936%,
1/15/35
(144A)
‡
56,802,000
56,890,918
Birch
Grove
CLO
10
Ltd.
2024-10A
A,
CME
Term
SOFR
3
Month
+
1.3900%,
5.9491%,
1/22/38
(144A)
‡
20,400,000
20,538,612
Birch
Grove
CLO
6
Ltd.
2023-6A
A1,
CME
Term
SOFR
3
Month
+
2.2000%,
6.4932%,
7/20/35
(144A)
‡
30,000,000
30,231,096
Birch
Grove
CLO
7
Ltd.
2023-7A
A1,
CME
Term
SOFR
3
Month
+
1.8000%,
6.0932%,
10/20/36
(144A)
‡
19,260,000
19,412,942
Black
Diamond
CLO
Ltd.
2019-2A
A1AR,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6103%,
7/23/32
(144A)
‡
37,616,856
37,682,291
BlueMountain
CLO
XXIV
Ltd.
2019-24A
AR,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6548%,
4/20/34
(144A)
‡
55,175,000
55,206,047
BlueMountain
CLO
XXV
Ltd.
2019-25A
A1RR,
CME
Term
SOFR
3
Month
+
1.3500%,
5.7616%,
1/15/38
(144A)
‡
110,000,000
110,550,000
BlueMountain
CLO
XXX
Ltd.
2020-30A
AR,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6720%,
4/15/35
(144A)
‡
15,960,000
15,988,600
BlueMountain
CLO
XXXI
Ltd.
2021-31A
A1,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7048%,
4/19/34
(144A)
‡
43,800,000
43,831,786
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
5
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
BlueMountain
CLO
XXXII
Ltd.
2021-32A
AR,
CME
Term
SOFR
3
Month
+
1.1000%,
5.3920%,
10/15/34
(144A)
‡
$
115,700,000
$
115,722,747
BlueMountain
CLO
XXXIII
Ltd.
2021-33A
A,
CME
Term
SOFR
3
Month
+
1.4516%,
5.9726%,
11/20/34
(144A)
‡
18,300,000
18,327,452
BlueMountain
CLO
XXXV
Ltd.
2022-35A
A1R,
CME
Term
SOFR
3
Month
+
1.4200%,
5.7101%,
10/22/37
(144A)
‡
81,000,000
81,612,036
BlueMountain
Fuji
US
CLO
III
Ltd.
2017-3A
A2,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7136%,
1/15/30
(144A)
‡
3,500,000
3,513,606
Bryant
Park
Funding
Ltd.
2023-19A
A1,
CME
Term
SOFR
3
Month
+
2.3500%,
6.6520%,
4/15/36
(144A)
‡
28,000,000
28,143,486
Canyon
Capital
CLO
Ltd.
2014-1A
A1BR,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7185%,
1/30/31
(144A)
‡
3,010,000
3,020,095
Canyon
Capital
CLO
Ltd.
2019-2A
AR2,
CME
Term
SOFR
3
Month
+
1.0100%,
0.0000%,
10/15/34
(144A)
†,‡
168,000,000
168,000,000
Canyon
CLO
Ltd.
2018-1A
A,
CME
Term
SOFR
3
Month
+
1.3316%,
5.6336%,
7/15/31
(144A)
‡
26,261,831
26,288,513
Canyon
CLO
Ltd.
2020-2A
AR2,
CME
Term
SOFR
3
Month
+
1.0300%,
5.3259%,
10/15/34
(144A)
‡
118,000,000
118,062,304
Canyon
CLO
Ltd.
2023-2A
A2,
CME
Term
SOFR
3
Month
+
1.7700%,
6.0720%,
5/15/37
(144A)
‡
15,000,000
15,141,053
Carlyle
C17
CLO
Ltd.
C17A
A1AR,
CME
Term
SOFR
3
Month
+
1.2916%,
5.5785%,
4/30/31
(144A)
‡
11,475,497
11,484,966
Carlyle
US
CLO
Ltd.
2021-3SA
A1,
CME
Term
SOFR
3
Month
+
1.3216%,
5.6236%,
4/15/34
(144A)
‡
16,800,000
16,826,900
Carlyle
US
CLO
Ltd.
2021-5A
A1,
CME
Term
SOFR
3
Month
+
1.3816%,
5.6748%,
7/20/34
(144A)
‡
29,500,000
29,558,283
Carlyle
US
CLO
Ltd.
2021-8A
A,
CME
Term
SOFR
3
Month
+
1.4216%,
5.7236%,
10/15/34
(144A)
‡
19,000,000
19,034,306
Carlyle
US
CLO
Ltd.
2020-2A
A1R,
CME
Term
SOFR
3
Month
+
1.4016%,
5.7017%,
1/25/35
(144A)
‡
53,060,000
53,155,057
Carlyle
US
CLO
Ltd.
2019-4A
A11R,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6220%,
4/15/35
(144A)
‡
22,770,000
22,806,537
Carlyle
US
CLO
Ltd.
2021-7A
A1,
CME
Term
SOFR
3
Month
+
1.4216%,
5.7236%,
10/15/35
(144A)
‡
83,200,000
83,350,842
Carlyle
US
CLO
Ltd.
2022-4A
A2R,
CME
Term
SOFR
3
Month
+
1.5700%,
5.8701%,
7/25/36
(144A)
‡
16,150,000
16,299,200
Carlyle
US
CLO
Ltd.
2024-3A
A2,
CME
Term
SOFR
3
Month
+
1.7200%,
6.0201%,
7/25/36
(144A)
‡
24,000,000
24,228,612
Carlyle
US
CLO
Ltd.
2022-3A
AR,
CME
Term
SOFR
3
Month
+
1.5500%,
5.8432%,
4/20/37
(144A)
‡
89,900,000
90,481,473
Carlyle
US
CLO
Ltd.
2017-2A
AR2,
CME
Term
SOFR
3
Month
+
1.4900%,
5.7832%,
7/20/37
(144A)
‡
71,080,000
71,556,670
Carlyle
US
CLO
Ltd.
2021-11A
A1R,
CME
Term
SOFR
3
Month
+
1.4100%,
5.7101%,
7/25/37
(144A)
‡
35,000,000
35,220,745
Carlyle
US
CLO
Ltd.
2019-2A
AR2,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6620%,
10/15/37
(144A)
‡
61,860,000
62,189,708
Carlyle
US
CLO
Ltd.
2022-5A
A2R,
CME
Term
SOFR
3
Month
+
1.6000%,
5.9020%,
10/15/37
(144A)
‡
25,000,000
25,041,500
Carlyle
US
CLO
Ltd.
2017-3A
A1R2,
CME
Term
SOFR
3
Month
+
1.4000%,
5.6932%,
10/21/37
(144A)
‡
48,000,000
48,341,122
Carlyle
US
CLO
Ltd.
2017-3A
A2R2,
CME
Term
SOFR
3
Month
+
1.5500%,
5.8432%,
10/21/37
(144A)
‡
11,000,000
11,101,727
Carlyle
US
CLO
Ltd.
2021-10A
A1R,
CME
Term
SOFR
3
Month
+
1.3100%,
5.6032%,
1/20/38
(144A)
‡
175,000,000
175,888,650
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
6
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Carlyle
US
CLO
Ltd.
2021-1A
A1AR,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6720%,
1/15/40
(144A)
‡
$
30,500,000
$
30,695,252
CarVal
CLO
II
Ltd.
2019-1A
AR2,
CME
Term
SOFR
3
Month
+
1.0200%,
5.3132%,
4/20/32
(144A)
‡
442,338
443,183
CBAM
Ltd.
2019-10A
A1R,
CME
Term
SOFR
3
Month
+
1.3816%,
5.6748%,
4/20/32
(144A)
‡
10,748,428
10,767,954
CBAM
Ltd.
2020-13A
A,
CME
Term
SOFR
3
Month
+
1.6916%,
5.9848%,
1/20/34
(144A)
‡
25,880,000
25,927,441
CBAM
Ltd.
2021-14A
A,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6548%,
4/20/34
(144A)
‡
75,000,000
75,043,020
CBAM
Ltd.
2019-11RA
A1,
CME
Term
SOFR
3
Month
+
1.4416%,
5.7348%,
1/20/35
(144A)
‡
16,897,000
16,912,221
CBAM
Ltd.
2019-11RA
A2,
CME
Term
SOFR
3
Month
+
1.7616%,
6.0548%,
1/20/35
(144A)
‡
13,889,000
13,922,022
CBAM
Ltd.
2017-1A
AR2,
CME
Term
SOFR
3
Month
+
1.3900%,
5.7701%,
1/20/38
(144A)
‡
133,000,000
133,993,111
CBAMR
Ltd.
2019-9A
AR,
CME
Term
SOFR
3
Month
+
1.6300%,
5.9320%,
7/15/37
(144A)
‡
50,000,000
50,382,845
Cedar
Funding
IV
CLO
Ltd.
2014-4A
AR3,
CME
Term
SOFR
3
Month
+
1.3400%,
5.6191%,
1/23/38
(144A)
‡
42,125,000
42,346,156
Cedar
Funding
IX
CLO
Ltd.
2018-9A
AR,
CME
Term
SOFR
3
Month
+
1.4200%,
5.7132%,
7/20/37
(144A)
‡
49,365,000
49,688,884
Cedar
Funding
VI
CLO
Ltd.
2016-6A
ARR,
CME
Term
SOFR
3
Month
+
1.3116%,
5.6048%,
4/20/34
(144A)
‡
80,219,000
80,259,061
Cedar
Funding
VIII
CLO
Ltd.
2017-8A
A1R,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7145%,
10/17/34
(144A)
‡
25,671,000
25,671,000
Cedar
Funding
XII
CLO
Ltd.
2020-12A
A1R,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6917%,
10/25/34
(144A)
‡
22,165,000
22,180,345
Cedar
Funding
XIV
CLO
Ltd.
2021-14A
AR,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6820%,
10/15/37
(144A)
‡
109,415,000
110,332,751
CIFC
Funding
2014-V
Ltd.
2014-5A
A1R3,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6829%,
7/17/37
(144A)
‡
77,872,000
78,251,385
CIFC
Funding
2014-V
Ltd.
2014-5A
A2R3,
CME
Term
SOFR
3
Month
+
1.5800%,
5.8829%,
7/17/37
(144A)
‡
11,250,000
11,258,603
CIFC
Funding
2016-I
Ltd.
2016-1A
AR3,
CME
Term
SOFR
3
Month
+
1.0000%,
5.2932%,
10/21/31
(144A)
‡
32,610,000
32,662,274
CIFC
Funding
2020-III
Ltd.
2020-3A
A1R,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6848%,
10/20/34
(144A)
‡
82,280,000
82,431,436
CIFC
Funding
2020-IV
Ltd.
2020-4A
A1R,
CME
Term
SOFR
3
Month
+
1.3000%,
5.7252%,
1/15/40
(144A)
‡
65,000,000
65,544,557
CIFC
Funding
2021-IV
Ltd.
2021-4A
AR,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6503%,
7/23/37
(144A)
‡
105,000,000
105,520,695
CIFC
Funding
2022-II
Ltd.
2022-2A
A1R,
CME
Term
SOFR
3
Month
+
0.9700%,
0.0000%,
4/19/35
(144A)
†,‡
115,000,000
115,000,000
CIFC
Funding
2022-II
Ltd.
2022-2A
A1,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6132%,
4/19/35
(144A)
‡
18,700,000
18,732,398
CIFC
Funding
2022-V
Ltd.
2022-5A
A2R,
CME
Term
SOFR
3
Month
+
1.7200%,
6.0276%,
1/16/37
(144A)
‡
10,000,000
10,092,220
CIFC
Funding
2024-III
Ltd.
2024-3A
A1,
CME
Term
SOFR
3
Month
+
1.4800%,
5.7732%,
7/21/37
(144A)
‡
66,000,000
66,487,403
CIFC
Funding
Ltd.
2019-5A
A1R1,
CME
Term
SOFR
3
Month
+
1.4016%,
5.7036%,
1/15/35
(144A)
‡
39,000,000
39,108,927
CIFC
Funding
Ltd.
2014-4RA
A1AR,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7345%,
1/17/35
(144A)
‡
110,755,000
110,942,353
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
7
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
CIFC
Funding
Ltd.
2021-7A
A1,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6819%,
1/23/35
(144A)
‡
$
74,601,000
$
74,742,779
CIFC
Funding
Ltd.
2022-4A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
6.0076%,
7/16/35
(144A)
‡
20,000,000
20,062,886
CIFC
Funding
Ltd.
2020-1A
A1R,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7136%,
7/15/36
(144A)
‡
68,560,000
68,680,638
CIFC
Funding
Ltd.
2014-2RA
AR,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6566%,
10/24/37
(144A)
‡
60,000,000
60,316,314
CIFC
Funding
Ltd.
2021-5A
A1R,
CME
Term
SOFR
3
Month
+
1.2600%,
5.5693%,
1/15/38
(144A)
‡
23,000,000
23,149,500
Clover
CLO
LLC
2021-3A
AR,
CME
Term
SOFR
3
Month
+
1.0700%,
5.3701%,
1/25/35
(144A)
‡
20,000,000
20,060,000
Clover
CLO
LLC
2018-1A
A2RR,
CME
Term
SOFR
3
Month
+
1.7300%,
6.0232%,
4/20/37
(144A)
‡
30,000,000
30,206,778
Columbia
Cent
CLO
29
Ltd.
2020-29A
AR,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7248%,
10/20/34
(144A)
‡
12,140,000
12,202,885
CQS
US
CLO
Ltd.
2023-3A
AJ,
CME
Term
SOFR
3
Month
+
2.1500%,
6.4501%,
1/25/37
(144A)
‡
9,000,000
9,082,787
Crown
City
CLO
IV
2022-4A
AJ,
CME
Term
SOFR
3
Month
+
1.8200%,
6.1132%,
4/20/37
(144A)
‡
19,000,000
19,167,933
Crown
Point
CLO
7
Ltd.
2018-7A
AR,
CME
Term
SOFR
3
Month
+
1.2300%,
5.5232%,
10/20/31
(144A)
‡
25,485,059
25,514,255
Crown
Point
CLO
8
Ltd.
2019-8A
AR,
CME
Term
SOFR
3
Month
+
1.4516%,
5.7448%,
10/20/34
(144A)
‡
20,000,000
20,006,678
Diameter
Capital
CLO
3
Ltd.
2022-3A
A1R,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6173%,
1/15/38
(144A)
‡
27,000,000
27,194,206
Dryden
105
CLO
Ltd.
2023-105A
A,
CME
Term
SOFR
3
Month
+
1.8000%,
6.0932%,
4/18/36
(144A)
‡
32,000,000
32,091,526
Dryden
105
CLO
Ltd.
2023-105A
C,
CME
Term
SOFR
3
Month
+
3.1000%,
7.3932%,
4/18/36
(144A)
‡
16,550,000
16,666,456
Dryden
106
CLO
Ltd.
2022-106A
A1R,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6620%,
10/15/37
(144A)
‡
60,000,000
60,333,660
Dryden
106
CLO
Ltd.
2022-106A
A2R,
CME
Term
SOFR
3
Month
+
1.5300%,
5.8320%,
10/15/37
(144A)
‡
15,000,000
15,014,466
Dryden
107
CLO
Ltd.
2023-107A
A2,
CME
Term
SOFR
3
Month
+
2.1500%,
6.6735%,
8/15/35
(144A)
‡
10,000,000
10,098,354
Dryden
108
CLO
Ltd.
2022-108A
A1R,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6532%,
7/18/37
(144A)
‡
90,000,000
90,423,837
Dryden
113
CLO
Ltd.
2022-113A
AR2,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5520%,
10/15/37
(144A)
‡
49,998,000
50,147,024
Dryden
115
CLO
Ltd.
2024-115A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
5.9932%,
4/18/37
(144A)
‡
40,000,000
40,254,444
Dryden
119
CLO
Ltd.
2024-119A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
6.0020%,
4/15/36
(144A)
‡
22,000,000
22,172,564
Dryden
121
CLO
Ltd.
2024-121A
A2,
CME
Term
SOFR
3
Month
+
1.5400%,
5.8740%,
1/15/37
(144A)
‡
33,000,000
33,252,354
Dryden
30
Senior
Loan
Fund
2013-30A
AR,
CME
Term
SOFR
3
Month
+
1.0816%,
5.6051%,
11/15/28
(144A)
‡
5,445,597
5,452,017
Dryden
43
Senior
Loan
Fund
2016-43A
AR3,
CME
Term
SOFR
3
Month
+
1.0700%,
5.3632%,
4/20/34
(144A)
‡
10,000,000
10,034,831
Dryden
45
Senior
Loan
Fund
2016-45A
A1RR,
CME
Term
SOFR
3
Month
+
1.0800%,
5.3820%,
10/15/30
(144A)
‡
30,045,538
30,094,071
Dryden
50
Senior
Loan
Fund
2017-50A
A1R,
CME
Term
SOFR
3
Month
+
1.2616%,
5.5636%,
7/15/30
(144A)
‡
7,472,947
7,479,029
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
8
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Dryden
75
CLO
Ltd.
2019-75A
AR2,
CME
Term
SOFR
3
Month
+
1.3016%,
5.6036%,
4/15/34
(144A)
‡
$
47,290,000
$
47,361,786
Dryden
76
CLO
Ltd.
2019-76A
A1R2,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6720%,
10/15/37
(144A)
‡
136,000,000
136,814,749
Dryden
77
CLO
Ltd.
2020-77A
AR,
CME
Term
SOFR
3
Month
+
1.3816%,
5.9026%,
5/20/34
(144A)
‡
145,774,633
145,929,854
Dryden
78
CLO
Ltd.
2020-78A
A2R,
CME
Term
SOFR
3
Month
+
1.7300%,
6.0329%,
4/17/37
(144A)
‡
10,000,000
10,026,440
Dryden
83
CLO
Ltd.
2020-83A
AR,
CME
Term
SOFR
3
Month
+
1.5300%,
5.8232%,
4/18/37
(144A)
‡
47,000,000
47,306,393
Dryden
85
CLO
Ltd.
2020-85A
A1R2,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6820%,
7/15/37
(144A)
‡
50,000,000
50,242,425
Dryden
86
CLO
Ltd.
2020-86A
A1R,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6645%,
7/17/34
(144A)
‡
37,135,000
37,198,118
Dryden
95
CLO
Ltd.
2021-95A
A,
CME
Term
SOFR
3
Month
+
1.3816%,
5.9026%,
8/20/34
(144A)
‡
73,000,000
73,077,066
Eaton
Vance
CLO
Ltd.
2019-1A
AR2,
CME
Term
SOFR
3
Month
+
1.5100%,
5.8120%,
7/15/37
(144A)
‡
62,500,000
63,045,056
Elevation
CLO
Ltd.
2021-13A
A1,
CME
Term
SOFR
3
Month
+
1.4516%,
5.7536%,
7/15/34
(144A)
‡
12,010,000
12,010,000
Elmwood
CLO
15
Ltd.
2022-2A
A1,
CME
Term
SOFR
3
Month
+
1.3400%,
5.6301%,
4/22/35
(144A)
‡
43,529,063
43,607,158
Elmwood
CLO
23
Ltd.
2023-2A
A,
CME
Term
SOFR
3
Month
+
1.8000%,
6.1076%,
4/16/36
(144A)
‡
40,000,000
40,069,792
Elmwood
CLO
24
Ltd.
2023-3A
AR,
CME
Term
SOFR
3
Month
+
1.3200%,
5.7680%,
1/17/38
(144A)
‡
108,850,000
109,796,766
Elmwood
CLO
25
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.7300%,
6.0329%,
4/17/37
(144A)
‡
10,000,000
10,087,338
Elmwood
CLO
26
Ltd.
2024-1A
A1,
CME
Term
SOFR
3
Month
+
1.5000%,
5.7932%,
4/18/37
(144A)
‡
60,000,000
60,424,686
Elmwood
CLO
30
Ltd.
2024-6A
A,
CME
Term
SOFR
3
Month
+
1.4300%,
5.7329%,
7/17/37
(144A)
‡
30,000,000
30,194,943
Elmwood
CLO
36
Ltd.
2024-12RA
AR,
CME
Term
SOFR
3
Month
+
1.3400%,
5.7451%,
10/20/37
(144A)
‡
15,650,000
15,780,660
Elmwood
CLO
I
Ltd.
2019-1A
A2RR,
CME
Term
SOFR
3
Month
+
1.7200%,
6.0132%,
4/20/37
(144A)
‡
8,750,000
8,835,231
Elmwood
CLO
III
Ltd.
2019-3A
A1RR,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6732%,
7/18/37
(144A)
‡
68,800,000
69,141,434
Elmwood
CLO
V
Ltd.
2020-2A
ARR,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6632%,
10/20/37
(144A)
‡
75,000,000
75,416,730
Empower
CLO
Ltd.
2023-2A
A2,
CME
Term
SOFR
3
Month
+
2.4000%,
6.7020%,
7/15/36
(144A)
‡
22,500,000
22,711,376
Empower
CLO
Ltd.
2024-1A
A1,
CME
Term
SOFR
3
Month
+
1.6000%,
5.9001%,
4/25/37
(144A)
‡
45,970,000
46,383,234
Empower
CLO
Ltd.
2022-1A
A1R,
CME
Term
SOFR
3
Month
+
1.3900%,
5.6832%,
10/20/37
(144A)
‡
37,500,000
37,864,755
Fortress
Credit
BSL
XVI
Ltd.
2022-3A
AR,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6632%,
10/20/35
(144A)
‡
9,000,000
9,026,928
Fortress
Credit
BSL
XXV
Ltd.
2024-2A
A,
CME
Term
SOFR
3
Month
+
1.6000%,
5.8966%,
7/24/37
(144A)
‡
10,200,000
10,304,663
Fortress
Credit
BSL
XXVI
Ltd.
2024-4A
A,
CME
Term
SOFR
3
Month
+
1.4000%,
5.7152%,
1/15/38
(144A)
‡
40,000,000
40,280,000
Galaxy
XXII
CLO
Ltd.
2016-22A
ARRR,
CME
Term
SOFR
3
Month
+
1.2400%,
5.5476%,
4/16/34
(144A)
‡
141,800,000
141,938,510
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
9
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Generate
CLO
13
Ltd.
2023-13A
A1,
CME
Term
SOFR
3
Month
+
1.8000%,
6.0901%,
1/20/37
(144A)
‡
$
71,500,000
$
72,105,626
Generate
CLO
9
Ltd.
9A
AR,
CME
Term
SOFR
3
Month
+
1.3500%,
5.6432%,
1/20/38
(144A)
‡
118,250,000
119,195,361
Generate
CLO
Ltd.
2024-17A
A1,
CME
Term
SOFR
3
Month
+
1.4000%,
5.6901%,
10/22/37
(144A)
‡
14,750,000
14,877,877
GoldenTree
Loan
Management
US
CLO
10
Ltd.
2021-10A
AJ,
CME
Term
SOFR
3
Month
+
1.5800%,
5.8732%,
10/20/37
(144A)
‡
18,900,000
19,046,753
GoldenTree
Loan
Management
US
CLO
4
Ltd.
2019-4A
ARR,
CME
Term
SOFR
3
Month
+
1.1500%,
5.4466%,
4/24/31
(144A)
‡
13,926,481
13,931,200
GoldenTree
Loan
Management
US
CLO
6
Ltd.
2019-6A
AR,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6132%,
4/20/35
(144A)
‡
16,600,000
16,626,689
Golub
Capital
Partners
CLO
58B
Ltd.
2021-58A
A2,
CME
Term
SOFR
3
Month
+
1.7116%,
6.0117%,
1/25/35
(144A)
‡
10,000,000
10,030,785
Golub
Capital
Partners
CLO
66B
Ltd.
2023-66A
A,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2501%,
4/25/36
(144A)
‡
49,670,000
49,896,227
Golub
Capital
Partners
CLO
72
B
Ltd.
2024-72A
A,
CME
Term
SOFR
3
Month
+
1.5500%,
5.8501%,
4/25/37
(144A)
‡
16,000,000
16,131,571
Golub
Capital
Partners
CLO
72
B
Ltd.
2024-72A
AJ,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0501%,
4/25/37
(144A)
‡
18,000,000
18,169,934
Harmony-Peace
Park
CLO
Ltd.
2024-1A
A,
CME
Term
SOFR
3
Month
+
1.3500%,
5.7854%,
10/20/37
(144A)
‡
61,500,000
61,830,975
Harvest
US
CLO
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.8500%,
6.1432%,
4/18/37
(144A)
‡
8,000,000
8,062,732
Hayfin
US
XV
Ltd.
2024-15A
A2,
CME
Term
SOFR
3
Month
+
1.9200%,
6.2198%,
4/28/37
(144A)
‡
8,000,000
8,099,541
HPS
Loan
Management
Ltd.
2021-16A
A1,
CME
Term
SOFR
3
Month
+
1.4016%,
5.6919%,
1/23/35
(144A)
‡
63,172,000
63,266,632
Invesco
CLO
Ltd.
2021-2A
A,
CME
Term
SOFR
3
Month
+
1.3816%,
5.6836%,
7/15/34
(144A)
‡
68,500,000
68,707,212
Invesco
CLO
Ltd.
2022-2A
A1,
CME
Term
SOFR
3
Month
+
1.4400%,
5.7332%,
7/20/35
(144A)
‡
16,500,000
16,516,309
Invesco
CLO
Ltd.
2022-2A
A2,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0432%,
7/20/35
(144A)
‡
5,000,000
5,013,841
Invesco
US
CLO
Ltd.
2023-1A
AR,
CME
Term
SOFR
3
Month
+
1.5700%,
5.8601%,
4/22/37
(144A)
‡
40,000,000
40,321,440
Invesco
US
CLO
Ltd.
2024-4A
A1,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6476%,
1/15/38
(144A)
‡
55,175,000
55,603,958
Katayma
CLO
I
Ltd.
2023-1A
A2,
CME
Term
SOFR
3
Month
+
2.2000%,
6.4932%,
10/20/36
(144A)
‡
16,000,000
16,157,541
Katayma
CLO
II
Ltd.
2024-2A
A1,
CME
Term
SOFR
3
Month
+
1.6500%,
5.9432%,
4/20/37
(144A)
‡
98,500,000
98,923,855
KKR
CLO
15
Ltd.
15
A1R2,
CME
Term
SOFR
3
Month
+
1.1000%,
5.3932%,
1/18/32
(144A)
‡
37,586,308
37,629,871
KKR
CLO
16
Ltd.
16
A1R2,
CME
Term
SOFR
3
Month
+
1.4716%,
5.7648%,
10/20/34
(144A)
‡
17,550,000
17,577,094
KKR
CLO
24
Ltd.
24
A1R,
CME
Term
SOFR
3
Month
+
1.3416%,
5.6348%,
4/20/32
(144A)
‡
6,463,672
6,472,109
KKR
CLO
27
Ltd.
27A
A1R2,
CME
Term
SOFR
3
Month
+
1.1100%,
5.5239%,
1/15/35
(144A)
‡
144,000,000
144,038,635
KKR
CLO
34
Ltd.
34A
B,
CME
Term
SOFR
3
Month
+
2.0616%,
6.3636%,
7/15/34
(144A)
‡
14,875,000
14,962,777
KKR
CLO
35
Ltd.
35A
A,
CME
Term
SOFR
3
Month
+
1.4516%,
5.7448%,
10/20/34
(144A)
‡
53,845,000
53,845,000
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
10
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
KKR
CLO
35
Ltd.
35A
AR,
CME
Term
SOFR
3
Month
+
1.2000%,
0.0000%,
1/20/38
(144A)
†,‡
$
90,345,000
$
90,345,000
KKR
CLO
36
Ltd.
36A
A,
CME
Term
SOFR
3
Month
+
1.4416%,
5.7436%,
10/15/34
(144A)
‡
17,530,000
17,584,255
KKR
CLO
37
Ltd.
37A
A1A,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7248%,
1/20/35
(144A)
‡
18,750,000
18,810,118
KKR
CLO
38
Ltd.
38A
A1,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6220%,
4/15/33
(144A)
‡
11,250,000
11,283,285
KKR
CLO
40
Ltd.
40A
AR,
CME
Term
SOFR
3
Month
+
1.3000%,
5.5932%,
10/20/34
(144A)
‡
14,975,000
14,999,059
KKR
CLO
41
Ltd.
2022-41A
A1,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6320%,
4/15/35
(144A)
‡
30,359,000
30,449,206
KKR
CLO
43
Ltd.
2022-43A
A1R,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0520%,
1/15/36
(144A)
‡
80,000,000
80,726,384
KKR
CLO
43
Ltd.
2022-43A
A2R,
CME
Term
SOFR
3
Month
+
2.0000%,
6.3020%,
1/15/36
(144A)
‡
11,750,000
11,887,906
KKR
CLO
44
Ltd.
44A
A2,
CME
Term
SOFR
3
Month
+
2.0500%,
6.3432%,
1/20/36
(144A)
‡
10,000,000
10,089,852
KKR
CLO
46
Ltd.
2023-46A
AR,
CME
Term
SOFR
3
Month
+
1.4000%,
5.6932%,
10/20/37
(144A)
‡
89,750,000
90,031,366
KKR
CLO
48
Ltd.
48A
A2,
CME
Term
SOFR
3
Month
+
2.0000%,
6.2932%,
10/20/36
(144A)
‡
8,750,000
8,815,824
KKR
CLO
49
Ltd.
49A
AR,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6732%,
10/20/37
(144A)
‡
32,000,000
32,175,693
KKR
CLO
54
Ltd.
2024-54A
A,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6409%,
1/15/38
(144A)
‡
163,750,000
165,039,187
KKR
CLO
56
Ltd.
2024-56A
A1,
CME
Term
SOFR
3
Month
+
1.4000%,
5.7020%,
10/15/37
(144A)
‡
28,000,000
28,270,544
LCM
29
Ltd.
29A
AR,
CME
Term
SOFR
3
Month
+
1.3316%,
5.6336%,
4/15/31
(144A)
‡
18,312,317
18,329,498
LCM
35
Ltd.
35A
A2,
CME
Term
SOFR
3
Month
+
1.6616%,
5.9636%,
10/15/34
(144A)
‡
7,000,000
7,014,750
LCM
Loan
Income
Fund
I
Income
Note
Issuer
Ltd.
27A
A2,
CME
Term
SOFR
3
Month
+
1.5616%,
5.8692%,
7/16/31
(144A)
‡
18,000,000
18,073,008
Madison
Park
Funding
LII
Ltd.
2021-52A
A,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6517%,
1/22/35
(144A)
‡
85,085,000
85,147,461
Madison
Park
Funding
LVII
Ltd.
2022-57A
A2R,
CME
Term
SOFR
3
Month
+
1.5000%,
5.8001%,
7/27/34
(144A)
‡
16,500,000
16,642,685
Madison
Park
Funding
LX
Ltd.
2022-60A
A1R,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6701%,
10/25/37
(144A)
‡
50,400,000
50,859,552
Madison
Park
Funding
LXIII
Ltd.
2023-63A
A2,
CME
Term
SOFR
3
Month
+
2.2500%,
6.5432%,
4/21/35
(144A)
‡
15,000,000
15,131,026
Madison
Park
Funding
LXIX
Ltd.
2024-69A
A2,
CME
Term
SOFR
3
Month
+
1.7100%,
6.0101%,
7/25/37
(144A)
‡
29,450,000
29,686,604
Madison
Park
Funding
LXVII
Ltd.
2024-67A
A1,
CME
Term
SOFR
3
Month
+
1.5100%,
5.8101%,
4/25/37
(144A)
‡
12,050,000
12,134,443
Madison
Park
Funding
XIV
Ltd.
2014-14A
AR3,
CME
Term
SOFR
3
Month
+
1.2000%,
5.4901%,
10/22/30
(144A)
‡
209,890,592
210,294,527
MADISON
PARK
FUNDING
XLII
Ltd.
13A
AR,
CME
Term
SOFR
3
Month
+
1.1500%,
5.4403%,
11/21/30
(144A)
‡
26,824,302
26,850,037
Madison
Park
Funding
XLVII
Ltd.
2020-47A
A2R,
CME
Term
SOFR
3
Month
+
1.7400%,
6.0332%,
4/19/37
(144A)
‡
16,000,000
16,152,739
Madison
Park
Funding
XXI
Ltd.
2016-21A
AARR,
CME
Term
SOFR
3
Month
+
1.3416%,
5.6436%,
10/15/32
(144A)
‡
96,287,448
96,411,697
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
11
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Madison
Park
Funding
XXIV
Ltd.
2016-24A
AR2,
CME
Term
SOFR
3
Month
+
1.1200%,
5.4132%,
10/20/29
(144A)
‡
$
5,273,447
$
5,279,346
Madison
Park
Funding
XXVIII
Ltd.
2018-28A
A2R,
CME
Term
SOFR
3
Month
+
1.5500%,
5.9752%,
1/15/38
(144A)
‡
15,575,000
15,679,793
Madison
Park
Funding
XXX
Ltd.
2018-30A
A1R,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6676%,
7/16/37
(144A)
‡
169,970,000
171,479,725
Madison
Park
Funding
XXXII
Ltd.
2018-32A
A1R2,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6501%,
7/22/37
(144A)
‡
83,250,000
83,910,722
Madison
Park
Funding
XXXII
Ltd.
2018-32A
A2R2,
CME
Term
SOFR
3
Month
+
1.5600%,
5.8501%,
7/22/37
(144A)
‡
24,000,000
24,161,489
Madison
Park
Funding
XXXIII
Ltd.
2019-33A
AR,
CME
Term
SOFR
3
Month
+
1.2900%,
5.5920%,
10/15/32
(144A)
‡
56,595,000
56,595,000
Madison
Park
Funding
XXXV
Ltd.
2019-35A
A1R,
CME
Term
SOFR
3
Month
+
1.2516%,
5.5448%,
4/20/32
(144A)
‡
10,626,467
10,651,790
Madison
Park
Funding
XXXVII
Ltd.
2019-37A
AR2,
CME
Term
SOFR
3
Month
+
1.5300%,
5.8320%,
4/15/37
(144A)
‡
30,000,000
30,201,360
Magnetite
XLVII
Ltd.
2024-47A
A,
CME
Term
SOFR
3
Month
+
1.3300%,
5.8024%,
1/25/38
(144A)
‡
108,500,000
109,585,000
Magnetite
XV
Ltd.
2015-15A
AR,
CME
Term
SOFR
3
Month
+
1.2716%,
5.5717%,
7/25/31
(144A)
‡
13,216,522
13,235,264
Magnetite
XXXII
Ltd.
2022-32A
A,
CME
Term
SOFR
3
Month
+
1.3500%,
5.6520%,
4/15/35
(144A)
‡
38,500,000
38,567,825
Magnetite
XXXIX
Ltd.
2023-39A
AR,
CME
Term
SOFR
3
Month
+
1.1700%,
5.4701%,
1/25/37
(144A)
‡
260,000,000
260,865,436
Man
US
CLO
Ltd.
2024-1A
A,
CME
Term
SOFR
3
Month
+
1.5500%,
5.8432%,
7/20/37
(144A)
‡
25,000,000
25,237,420
Marathon
CLO
XIII
Ltd.
2019-1A
ABR2,
CME
Term
SOFR
3
Month
+
1.7000%,
6.0020%,
4/15/32
(144A)
‡
12,500,000
12,526,746
Meacham
Park
CLO
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.5300%,
6.3185%,
10/20/37
(144A)
‡
10,000,000
10,067,980
Morgan
Stanley
Eaton
Vance
CLO
Ltd.
2021-1A
B,
CME
Term
SOFR
3
Month
+
1.9116%,
6.2020%,
10/20/34
(144A)
‡
10,845,000
10,885,534
Morgan
Stanley
Eaton
Vance
CLO
Ltd.
2023-20A
A2,
CME
Term
SOFR
3
Month
+
2.0000%,
6.2932%,
1/20/37
(144A)
‡
8,000,000
8,077,141
Nassau
Ltd.
2021-IA
A1R,
CME
Term
SOFR
3
Month
+
1.1100%,
5.4026%,
8/26/34
(144A)
‡
127,815,000
127,904,470
Neuberger
Berman
CLO
XIV
Ltd.
2013-14A
AR2,
CME
Term
SOFR
3
Month
+
1.2916%,
5.5915%,
1/28/30
(144A)
‡
5,201,967
5,207,084
Neuberger
Berman
CLO
XVII
Ltd.
2014-17A
AR3,
CME
Term
SOFR
3
Month
+
1.4000%,
5.6901%,
7/22/38
(144A)
‡
31,500,000
31,717,082
Neuberger
Berman
CLO
XXI
Ltd.
2016-21A
A1R3,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6132%,
1/20/39
(144A)
‡
83,000,000
83,767,244
Neuberger
Berman
CLO
XXII
Ltd.
2016-22A
A2R2,
CME
Term
SOFR
3
Month
+
1.7200%,
6.0229%,
4/15/38
(144A)
‡
15,200,000
15,341,314
Neuberger
Berman
Loan
Advisers
CLO
24
Ltd.
2017-24A
AR2,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6501%,
10/19/38
(144A)
‡
66,475,000
67,033,011
Neuberger
Berman
Loan
Advisers
CLO
26
Ltd.
2017-26A
AR2,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6532%,
10/18/38
(144A)
‡
64,662,000
65,027,049
Neuberger
Berman
Loan
Advisers
CLO
30
Ltd.
2018-30A
A1R2,
CME
Term
SOFR
3
Month
+
1.2400%,
5.5189%,
1/20/37
(144A)
‡
32,970,000
33,237,390
Neuberger
Berman
Loan
Advisers
CLO
42
Ltd.
2021-42A
A,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6692%,
7/16/35
(144A)
‡
28,008,725
28,058,298
Neuberger
Berman
Loan
Advisers
CLO
43
Ltd.
2021-43A
A,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6945%,
7/17/35
(144A)
‡
92,120,183
92,293,562
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
12
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Neuberger
Berman
Loan
Advisers
CLO
45
Ltd.
2021-45A
A,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6786%,
10/14/35
(144A)
‡
$
39,290,000
$
39,357,646
Neuberger
Berman
Loan
Advisers
CLO
47
Ltd.
2022-47A
A,
CME
Term
SOFR
3
Month
+
1.3000%,
5.5870%,
4/14/35
(144A)
‡
37,700,000
37,756,128
Neuberger
Berman
Loan
Advisers
CLO
55
Ltd.
2024-55A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
5.9901%,
4/22/38
(144A)
‡
24,750,000
24,969,424
Neuberger
Berman
Loan
Advisers
NBLA
CLO
53
Ltd.
2023-53A
A2R,
CME
Term
SOFR
3
Month
+
1.5400%,
6.0886%,
10/24/37
(144A)
‡
33,000,000
33,030,142
New
Mountain
CLO
2
Ltd.
CLO-2A
A1R,
CME
Term
SOFR
3
Month
+
1.3600%,
5.7193%,
1/15/38
(144A)
‡
51,000,000
51,356,796
New
Mountain
CLO
6
Ltd.
CLO-6A
A,
CME
Term
SOFR
3
Month
+
1.4000%,
6.0390%,
10/15/37
(144A)
‡
27,500,000
27,735,351
Northwoods
Capital
XIV-B
Ltd.
2018-14BA
AR,
CME
Term
SOFR
3
Month
+
1.2500%,
5.7662%,
11/13/31
(144A)
‡
44,722,884
44,749,481
NYACK
Park
CLO
Ltd.
2021-1A
A,
CME
Term
SOFR
3
Month
+
1.3816%,
5.6748%,
10/20/34
(144A)
‡
83,751,613
83,898,832
Oaktree
CLO
Ltd.
2021-2A
AR,
CME
Term
SOFR
3
Month
+
0.9700%,
0.0000%,
1/15/35
(144A)
†,‡
150,000,000
150,000,000
Oaktree
CLO
Ltd.
2022-3A
A1R,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6820%,
10/15/37
(144A)
‡
27,000,000
27,202,546
Oaktree
CLO
Ltd.
2020-1A
ARR,
CME
Term
SOFR
3
Month
+
1.1900%,
0.0000%,
1/15/38
(144A)
†,‡
96,600,000
96,600,000
Oaktree
CLO
Ltd.
2019-3A
A1R2,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6732%,
1/20/38
(144A)
‡
41,000,000
41,334,896
Oaktree
CLO
Ltd.
2019-3A
A2R2,
CME
Term
SOFR
3
Month
+
1.5800%,
5.8732%,
1/20/38
(144A)
‡
20,200,000
20,315,889
Ocean
Trails
CLO
XIV
Ltd.
2023-14A
AR,
CME
Term
SOFR
3
Month
+
1.3400%,
5.6332%,
1/20/38
(144A)
‡
125,000,000
126,061,962
OCP
Aegis
CLO
Ltd.
2024-39A
A1,
CME
Term
SOFR
3
Month
+
1.2200%,
5.7167%,
1/16/37
(144A)
‡
150,000,000
150,320,430
OCP
Aegis
CLO
Ltd.
2024-39A
A2,
CME
Term
SOFR
3
Month
+
1.4200%,
5.9167%,
1/16/37
(144A)
‡
12,000,000
12,025,750
OCP
CLO
Ltd.
2016-11A
A2R2,
CME
Term
SOFR
3
Month
+
1.7000%,
6.0001%,
4/26/36
(144A)
‡
12,000,000
12,028,590
OCP
CLO
Ltd.
2015-9A
AR3,
CME
Term
SOFR
3
Month
+
1.1000%,
0.0000%,
1/15/37
(144A)
†,‡
80,000,000
80,028,480
OCP
CLO
Ltd.
2021-23A
AR,
CME
Term
SOFR
3
Month
+
1.1600%,
5.4417%,
1/17/37
(144A)
‡
266,700,000
266,960,273
OCP
CLO
Ltd.
2020-20A
A2R,
CME
Term
SOFR
3
Month
+
1.7300%,
6.0232%,
4/18/37
(144A)
‡
16,000,000
16,110,205
OCP
CLO
Ltd.
2024-31A
A1,
CME
Term
SOFR
3
Month
+
1.6300%,
5.9232%,
4/20/37
(144A)
‡
24,750,000
24,979,316
OCP
CLO
Ltd.
2024-32A
A1,
CME
Term
SOFR
3
Month
+
1.5200%,
5.8103%,
4/23/37
(144A)
‡
77,000,000
77,768,814
OCP
CLO
Ltd.
2024-32A
A2,
CME
Term
SOFR
3
Month
+
1.7200%,
6.0103%,
4/23/37
(144A)
‡
12,000,000
12,082,861
OCP
CLO
Ltd.
2017-14A
A1R,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6632%,
7/20/37
(144A)
‡
187,000,000
188,546,546
OCP
CLO
Ltd.
2020-18A
A1R2,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6632%,
7/20/37
(144A)
‡
102,500,000
103,351,857
OCP
CLO
Ltd.
2022-25A
A1R,
CME
Term
SOFR
3
Month
+
1.4200%,
5.7132%,
7/20/37
(144A)
‡
64,650,000
65,200,967
OCP
CLO
Ltd.
2022-25A
A2R,
CME
Term
SOFR
3
Month
+
1.6200%,
5.9132%,
7/20/37
(144A)
‡
10,000,000
10,071,381
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
13
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
OCP
CLO
Ltd.
2021-22A
AR,
CME
Term
SOFR
3
Month
+
1.3500%,
5.6432%,
10/20/37
(144A)
‡
$
35,070,000
$
35,143,991
OCP
CLO
Ltd.
2018-15A
AR,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5433%,
1/20/38
(144A)
‡
95,000,000
95,570,000
Octagon
52
Ltd.
2021-1A
A2R,
CME
Term
SOFR
3
Month
+
1.6000%,
5.8903%,
7/23/37
(144A)
‡
10,000,000
10,011,895
Octagon
54
Ltd.
2021-1A
A1,
CME
Term
SOFR
3
Month
+
1.3816%,
5.6836%,
7/15/34
(144A)
‡
29,400,000
29,445,564
Octagon
55
Ltd.
2021-1A
A1,
CME
Term
SOFR
3
Month
+
1.4016%,
5.6948%,
7/20/34
(144A)
‡
40,000,000
40,065,904
Octagon
59
Ltd.
2022-1A
B,
CME
Term
SOFR
3
Month
+
1.9500%,
6.4735%,
5/15/35
(144A)
‡
40,000,000
40,126,888
Octagon
60
Ltd.
2022-1A
A2R,
CME
Term
SOFR
3
Month
+
1.5800%,
5.8732%,
10/20/37
(144A)
‡
15,000,000
15,131,193
Octagon
65
Ltd.
2024-4A
A2,
CME
Term
SOFR
3
Month
+
1.5800%,
6.2077%,
10/23/37
(144A)
‡
18,750,000
18,933,021
Octagon
68
Ltd.
2023-1A
A2,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2432%,
10/20/36
(144A)
‡
15,000,000
15,136,503
Octagon
69
Ltd.
2024-3A
A2,
CME
Term
SOFR
3
Month
+
1.6600%,
5.9566%,
7/24/37
(144A)
‡
10,000,000
10,094,207
Octagon
70
Alto
Ltd.
2023-1A
A2,
CME
Term
SOFR
3
Month
+
2.0500%,
6.3432%,
10/20/36
(144A)
‡
18,000,000
18,144,864
Octagon
71
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
5.9932%,
4/18/37
(144A)
‡
15,000,000
15,147,837
Octagon
Investment
Partners
18-R
Ltd.
2018-18A
A1A,
CME
Term
SOFR
3
Month
+
1.2216%,
5.5292%,
4/16/31
(144A)
‡
7,247,572
7,256,043
Octagon
Investment
Partners
20-R
Ltd.
2019-4A
A1RR,
CME
Term
SOFR
3
Month
+
1.4000%,
5.9216%,
8/12/37
(144A)
‡
28,000,000
28,156,156
Octagon
Investment
Partners
28
Ltd.
2016-1A
A2RR,
CME
Term
SOFR
3
Month
+
1.7200%,
6.0166%,
4/24/37
(144A)
‡
10,250,000
10,360,981
Octagon
Investment
Partners
29
Ltd.
2016-1A
A1R2,
CME
Term
SOFR
3
Month
+
1.4200%,
5.7132%,
7/18/37
(144A)
‡
63,900,000
64,260,760
Octagon
Investment
Partners
29
Ltd.
2016-1A
A2R2,
CME
Term
SOFR
3
Month
+
1.6200%,
5.9132%,
7/18/37
(144A)
‡
10,000,000
10,016,378
Octagon
Investment
Partners
32
Ltd.
2017-1A
A1R3,
CME
Term
SOFR
3
Month
+
1.3800%,
5.9907%,
10/31/37
(144A)
‡
87,000,000
87,476,516
Octagon
Investment
Partners
42
Ltd.
2019-3A
A1RR,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6620%,
7/15/37
(144A)
‡
97,000,000
97,436,587
Octagon
Investment
Partners
44
Ltd.
2019-1A
AR,
CME
Term
SOFR
3
Month
+
1.4416%,
5.7436%,
10/15/34
(144A)
‡
62,600,000
62,700,460
Octagon
Investment
Partners
45
Ltd.
2019-1A
A1R,
CME
Term
SOFR
3
Month
+
1.3400%,
5.6420%,
4/15/35
(144A)
‡
10,320,000
10,335,524
Octagon
Investment
Partners
46
Ltd.
2020-2A
AR,
CME
Term
SOFR
3
Month
+
1.4216%,
5.7236%,
7/15/36
(144A)
‡
31,705,000
31,754,878
Octagon
Investment
Partners
49
Ltd.
2020-5A
AR,
CME
Term
SOFR
3
Month
+
1.5200%,
5.8220%,
4/15/37
(144A)
‡
122,000,000
122,739,210
Octagon
Investment
Partners
50
Ltd.
2020-4A
AR,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7136%,
1/15/35
(144A)
‡
53,400,000
53,484,527
Octagon
Investment
Partners
51
Ltd.
2021-1A
A,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7048%,
7/20/34
(144A)
‡
64,835,000
64,941,582
Octagon
Investment
Partners
XIV
Ltd.
2012-1A
ABRR,
CME
Term
SOFR
3
Month
+
1.5116%,
5.8136%,
7/15/29
(144A)
‡
6,877,661
6,902,561
Octagon
Investment
Partners
XXI
Ltd.
2014-1A
AAR3,
CME
Term
SOFR
3
Month
+
1.2616%,
5.7784%,
2/14/31
(144A)
‡
22,510,118
22,518,715
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
14
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
OHA
Credit
Funding
11
Ltd.
2022-11A
A2R,
CME
Term
SOFR
3
Month
+
1.5200%,
5.8132%,
7/19/37
(144A)
‡
$
9,000,000
$
9,007,453
OHA
Credit
Funding
15
Ltd.
2023-15A
A,
CME
Term
SOFR
3
Month
+
1.8300%,
6.1232%,
4/20/35
(144A)
‡
14,300,000
14,353,725
OHA
Credit
Funding
3
Ltd.
2019-3A
AR2,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6132%,
1/20/38
(144A)
‡
10,000,000
10,091,500
OHA
Credit
Funding
7
Ltd.
2020-7A
AR,
CME
Term
SOFR
3
Month
+
1.3000%,
5.5901%,
2/24/37
(144A)
‡
48,500,000
48,592,426
OHA
Credit
Partners
XII
Ltd.
2015-12A
A2R2,
CME
Term
SOFR
3
Month
+
1.7000%,
5.9903%,
4/23/37
(144A)
‡
30,750,000
30,961,548
OHA
Credit
Partners
XIV
Ltd.
2017-14A
A2R,
CME
Term
SOFR
3
Month
+
1.5700%,
5.8632%,
7/21/37
(144A)
‡
20,000,000
20,135,608
OHA
Credit
Partners
XVI
2021-16A
AR,
CME
Term
SOFR
3
Month
+
1.3500%,
5.6432%,
10/18/37
(144A)
‡
45,500,000
45,908,899
OHA
Loan
Funding
Ltd.
2016-1A
A2R2,
CME
Term
SOFR
3
Month
+
1.6500%,
5.9432%,
7/20/37
(144A)
‡
20,500,000
20,547,933
Onex
CLO
Subsidiary
Ltd.
2024-33A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
5.9932%,
7/20/37
(144A)
‡
12,000,000
12,112,817
Palmer
Square
CLO
Ltd.
2015-1A
A1A5,
CME
Term
SOFR
3
Month
+
1.0500%,
5.3382%,
5/21/34
(144A)
‡
80,927,000
81,028,102
Palmer
Square
CLO
Ltd.
2015-1A
A1B5,
CME
Term
SOFR
3
Month
+
1.3500%,
5.6382%,
5/21/34
(144A)
‡
29,000,000
29,005,794
Palmer
Square
CLO
Ltd.
2021-2A
A,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7136%,
7/15/34
(144A)
‡
16,600,000
16,626,774
Palmer
Square
CLO
Ltd.
2021-4A
A,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7336%,
10/15/34
(144A)
‡
29,400,000
29,444,100
Palmer
Square
CLO
Ltd.
2021-3A
A2,
CME
Term
SOFR
3
Month
+
1.6616%,
5.9636%,
1/15/35
(144A)
‡
16,000,000
16,048,042
Palmer
Square
CLO
Ltd.
2022-1A
A,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6132%,
4/20/35
(144A)
‡
35,935,000
36,006,755
Palmer
Square
CLO
Ltd.
2022-3A
A2R,
CME
Term
SOFR
3
Month
+
1.5500%,
5.8432%,
7/20/37
(144A)
‡
15,400,000
15,503,362
Palmer
Square
CLO
Ltd.
2024-2A
A2,
CME
Term
SOFR
3
Month
+
1.6000%,
5.8932%,
7/20/37
(144A)
‡
6,000,000
6,051,625
Palmer
Square
Loan
Funding
Ltd.
2022-3A
A1BR,
CME
Term
SOFR
3
Month
+
1.4000%,
5.7020%,
4/15/31
(144A)
‡
500,000
501,300
Park
Blue
CLO
2023-IV
Ltd.
2023-4A
A2,
CME
Term
SOFR
3
Month
+
2.0000%,
6.3001%,
1/25/37
(144A)
‡
5,000,000
5,045,148
Park
Blue
CLO
2024-V
Ltd.
2024-5A
A1,
CME
Term
SOFR
3
Month
+
1.4800%,
5.7801%,
7/25/37
(144A)
‡
20,515,000
20,694,478
Peace
Park
CLO
Ltd.
2021-1A
A,
CME
Term
SOFR
3
Month
+
1.3916%,
5.6848%,
10/20/34
(144A)
‡
39,014,000
39,090,155
Pikes
Peak
CLO
8
2021-8A
A1R,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6232%,
1/20/38
(144A)
‡
10,000,000
10,068,000
Post
CLO
Ltd.
2023-1A
A,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2432%,
4/20/36
(144A)
‡
30,000,000
30,133,041
Post
CLO
Ltd.
2024-1A
A1,
CME
Term
SOFR
3
Month
+
1.6000%,
5.8932%,
4/20/37
(144A)
‡
85,000,000
85,748,238
Post
CLO
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.8000%,
6.0932%,
4/20/37
(144A)
‡
8,000,000
8,075,617
PPM
CLO
6-R
Ltd.
2022-6RA
A2R,
CME
Term
SOFR
3
Month
+
2.1500%,
6.4432%,
1/20/37
(144A)
‡
8,000,000
8,103,124
Rad
CLO
10
Ltd.
2021-10A
A,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7220%,
4/23/34
(144A)
‡
35,520,000
35,637,610
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
15
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
RAD
CLO
15
Ltd.
2021-15A
A,
CME
Term
SOFR
3
Month
+
1.3516%,
5.6448%,
1/20/34
(144A)
‡
$
22,400,000
$
22,468,322
Rad
CLO
18
Ltd.
2023-18A
A1,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2520%,
4/15/36
(144A)
‡
38,000,000
38,161,690
RAD
CLO
19
Ltd.
2023-19A
C,
CME
Term
SOFR
3
Month
+
3.3500%,
7.6432%,
4/20/35
(144A)
‡
15,500,000
15,576,334
RAD
CLO
21
Ltd.
2023-21A
A,
CME
Term
SOFR
3
Month
+
1.5900%,
5.8901%,
1/25/33
(144A)
‡
26,000,000
26,000,000
RAD
CLO
21
Ltd.
2023-21A
C,
CME
Term
SOFR
3
Month
+
2.5500%,
6.8501%,
1/25/33
(144A)
‡
17,335,572
17,335,572
RAD
CLO
21
Ltd.
2023-21A
A1R,
CME
Term
SOFR
3
Month
+
1.0700%,
0.0000%,
1/25/37
(144A)
†,‡
218,900,000
218,900,000
RAD
CLO
23
Ltd.
2024-23A
A1,
CME
Term
SOFR
3
Month
+
1.6000%,
5.8932%,
4/20/37
(144A)
‡
100,000,000
100,873,610
Rad
CLO
25
Ltd.
2024-25A
A1,
CME
Term
SOFR
3
Month
+
1.4600%,
5.7532%,
7/20/37
(144A)
‡
75,000,000
75,664,605
RAD
CLO
26
Ltd.
2024-26A
A,
CME
Term
SOFR
3
Month
+
1.3700%,
5.9620%,
10/20/37
(144A)
‡
100,000,000
100,155,830
Rad
CLO
5
Ltd.
2019-5A
AR,
CME
Term
SOFR
3
Month
+
1.3816%,
5.6783%,
7/24/32
(144A)
‡
11,466,681
11,484,774
Rad
CLO
7
Ltd.
2020-7A
A1R,
CME
Term
SOFR
3
Month
+
1.3500%,
5.6529%,
4/17/36
(144A)
‡
12,550,000
12,564,975
Rad
CLO
7
Ltd.
2020-7A
A2R,
CME
Term
SOFR
3
Month
+
1.7000%,
6.0029%,
4/17/36
(144A)
‡
11,000,000
11,033,242
Rad
CLO
9
Ltd.
2020-9A
A1R,
CME
Term
SOFR
3
Month
+
1.3400%,
5.6554%,
1/15/38
(144A)
‡
21,500,000
21,688,226
REESE
PARK
CLO
Ltd.
2020-1A
ARR,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6220%,
1/15/38
(144A)
‡
26,300,000
26,497,118
Regatta
30
Funding
Ltd.
2024-4A
A1,
CME
Term
SOFR
3
Month
+
1.3200%,
5.6330%,
1/25/38
(144A)
‡
48,500,000
48,924,375
Regatta
VI
Funding
Ltd.
2016-1A
AR2,
CME
Term
SOFR
3
Month
+
1.4216%,
5.7148%,
4/20/34
(144A)
‡
19,140,000
19,155,651
Regatta
XI
Funding
Ltd.
2018-1A
AR,
CME
Term
SOFR
3
Month
+
1.4000%,
5.7029%,
7/17/37
(144A)
‡
68,209,866
68,574,489
Regatta
XIV
Funding
Ltd.
2018-3A
AR,
CME
Term
SOFR
3
Month
+
1.1000%,
5.4001%,
10/25/31
(144A)
‡
36,154,951
36,209,183
Regatta
XVII
Funding
Ltd.
2020-1A
AR,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6820%,
10/15/37
(144A)
‡
31,250,000
31,438,734
Regatta
XX
Funding
Ltd.
2021-2A
A,
CME
Term
SOFR
3
Month
+
1.4216%,
5.7236%,
10/15/34
(144A)
‡
18,231,453
18,231,453
Regatta
XXII
Funding
Ltd.
2022-2A
AR,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5432%,
7/20/35
(144A)
‡
10,000,000
10,024,474
Regatta
XXV
Funding
Ltd.
2023-1A
A,
CME
Term
SOFR
3
Month
+
1.9000%,
6.2020%,
7/15/36
(144A)
‡
10,000,000
10,048,383
Regatta
XXVII
Funding
Ltd.
2024-1A
A1,
CME
Term
SOFR
3
Month
+
1.5300%,
5.8301%,
4/26/37
(144A)
‡
69,000,000
69,504,970
Regatta
XXVII
Funding
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.7300%,
6.0301%,
4/26/37
(144A)
‡
10,000,000
10,094,101
Regatta
XXVIII
Funding
Ltd.
2024-2A
A1,
CME
Term
SOFR
3
Month
+
1.5500%,
5.8501%,
4/25/37
(144A)
‡
75,000,000
75,572,220
Regatta
XXVIII
Funding
Ltd.
2024-2A
A2,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0501%,
4/25/37
(144A)
‡
16,000,000
16,142,354
Riserva
CLO
Ltd.
2016-3A
ARR,
CME
Term
SOFR
3
Month
+
1.3216%,
5.6148%,
1/18/34
(144A)
‡
74,500,000
74,613,285
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
16
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Rockford
Tower
CLO
Ltd.
2017-1A
AR2,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6548%,
4/20/34
(144A)
‡
$
14,500,000
$
14,545,310
Rockford
Tower
CLO
Ltd.
2022-2A
A2R,
CME
Term
SOFR
3
Month
+
2.1500%,
6.4432%,
10/20/35
(144A)
‡
9,500,000
9,588,460
Rockford
Tower
CLO
Ltd.
2021-3A
A2R,
CME
Term
SOFR
3
Month
+
1.6500%,
6.0919%,
1/15/38
(144A)
‡
14,000,000
14,014,241
RR
1
LLC
2017-1A
A1AB,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7136%,
7/15/35
(144A)
‡
68,865,000
68,980,590
RR
12
Ltd.
2020-12A
AAR3,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5520%,
1/15/36
(144A)
‡
14,115,000
14,134,954
RR
16
Ltd.
2021-16A
A1,
CME
Term
SOFR
3
Month
+
1.3716%,
5.6736%,
7/15/36
(144A)
‡
19,810,000
19,844,109
RR
21
Ltd.
2022-21A
A1AR,
CME
Term
SOFR
3
Month
+
1.4000%,
5.7020%,
7/15/39
(144A)
‡
47,800,000
48,074,520
RR
21
Ltd.
2022-21A
A1BR,
CME
Term
SOFR
3
Month
+
1.6000%,
5.9020%,
7/15/39
(144A)
‡
15,000,000
15,116,201
RR
5
Ltd.
2018-5A
A1R,
CME
Term
SOFR
3
Month
+
1.5000%,
5.8020%,
7/15/39
(144A)
‡
57,325,000
57,773,218
RR15
Ltd.
2021-15A
A1,
CME
Term
SOFR
3
Month
+
1.3616%,
5.6636%,
4/15/36
(144A)
‡
31,500,000
31,548,526
RRX
7
Ltd.
2022-7A
A1,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6620%,
7/15/35
(144A)
‡
21,350,000
21,392,638
Sagard-Halseypoint
CLO
8
Ltd.
2024-8A
A1,
CME
Term
SOFR
3
Month
+
1.3900%,
5.7044%,
1/30/38
(144A)
‡
14,290,000
14,400,747
Sandstone
Peak
II
Ltd.
2023-1A
C,
CME
Term
SOFR
3
Month
+
3.5000%,
7.7932%,
7/20/36
(144A)
‡
13,600,000
13,791,298
Sandstone
Peak
III
Ltd.
2024-1A
A1,
CME
Term
SOFR
3
Month
+
1.6300%,
5.9301%,
4/25/37
(144A)
‡
66,000,000
66,621,852
Sandstone
Peak
III
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.8300%,
6.1301%,
4/25/37
(144A)
‡
8,000,000
8,066,896
Sandstone
Peak
III
Ltd.
2024-1A
C,
CME
Term
SOFR
3
Month
+
2.6500%,
6.9501%,
4/25/37
(144A)
‡
21,500,000
21,818,458
Saratoga
Investment
Corp.
CLO
Ltd.
2013-1A
A2R4,
CME
Term
SOFR
3
Month
+
1.7600%,
6.0532%,
4/20/33
(144A)
‡
10,000,000
10,020,838
Shackleton
CLO
Ltd.
2019-14A
A1R,
CME
Term
SOFR
3
Month
+
1.4616%,
5.7548%,
7/20/34
(144A)
‡
22,150,000
22,166,694
Signal
Peak
CLO
11
Ltd.
2024-11A
A2,
CME
Term
SOFR
3
Month
+
1.6800%,
5.9732%,
7/18/37
(144A)
‡
20,000,000
20,138,256
Signal
Peak
CLO
12
Ltd.
2022-12A
A1R,
CME
Term
SOFR
3
Month
+
1.4000%,
5.6932%,
7/18/37
(144A)
‡
70,000,000
70,459,207
Signal
Peak
CLO
12
Ltd.
2022-12A
A2R,
CME
Term
SOFR
3
Month
+
1.6000%,
5.8932%,
7/18/37
(144A)
‡
8,000,000
8,030,979
Signal
Peak
CLO
14
Ltd.
2024-14A
A,
CME
Term
SOFR
3
Month
+
1.3000%,
5.5901%,
1/22/38
(144A)
‡
13,000,000
13,054,600
Signal
Peak
CLO
4
Ltd.
2017-4A
AR,
CME
Term
SOFR
3
Month
+
1.4416%,
5.7417%,
10/26/34
(144A)
‡
33,950,000
33,975,211
Signal
Peak
CLO
5
Ltd.
2018-5A
A2R,
CME
Term
SOFR
3
Month
+
1.7500%,
6.0501%,
4/25/37
(144A)
‡
24,000,000
24,201,370
Silver
Point
CLO
4
Ltd.
2024-4A
A1,
CME
Term
SOFR
3
Month
+
1.6300%,
5.9320%,
4/15/37
(144A)
‡
100,000,000
100,894,970
Silver
Point
CLO
4
Ltd.
2024-4A
A2,
CME
Term
SOFR
3
Month
+
1.8300%,
6.1320%,
4/15/37
(144A)
‡
18,000,000
18,161,420
Silver
Rock
CLO
I
Ltd.
2020-1A
A1RR,
CME
Term
SOFR
3
Month
+
1.4200%,
5.7132%,
10/20/37
(144A)
‡
50,000,000
50,501,635
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
17
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Silver
Rock
CLO
III
2023-3A
A2,
CME
Term
SOFR
3
Month
+
2.1000%,
6.3932%,
1/20/36
(144A)
‡
$
20,000,000
$
20,197,288
Sixth
Street
CLO
IX
Ltd.
2017-9A
AR,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6732%,
7/21/37
(144A)
‡
51,445,000
51,865,398
Sixth
Street
CLO
XV
Ltd.
2020-15A
AR,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6666%,
10/24/37
(144A)
‡
18,800,000
18,975,265
Sixth
Street
CLO
XVI
Ltd.
2020-16A
A2R,
CME
Term
SOFR
3
Month
+
1.9500%,
6.2432%,
1/20/37
(144A)
‡
5,500,000
5,546,448
Sixth
Street
CLO
XXIV
Ltd.
2024-24A
A,
CME
Term
SOFR
3
Month
+
1.5200%,
5.8103%,
4/23/37
(144A)
‡
51,590,000
51,989,755
Sound
Point
CLO
IX
Ltd.
2015-2A
ARRR,
CME
Term
SOFR
3
Month
+
1.4716%,
5.7648%,
7/20/32
(144A)
‡
63,624,493
63,734,582
Sound
Point
CLO
VI-R
Ltd.
2014-2RA
A,
CME
Term
SOFR
3
Month
+
1.5116%,
5.8048%,
10/20/31
(144A)
‡
4,808,212
4,818,513
Sound
Point
CLO
XXVI
Ltd.
2020-1A
AR,
CME
Term
SOFR
3
Month
+
1.4316%,
5.7248%,
7/20/34
(144A)
‡
10,000,000
10,006,257
Steele
Creek
CLO
Ltd.
2014-1RA
A,
CME
Term
SOFR
3
Month
+
1.3316%,
5.6248%,
4/21/31
(144A)
‡
497,198
497,399
Steele
Creek
CLO
Ltd.
2018-2A
A,
CME
Term
SOFR
3
Month
+
1.4616%,
5.9470%,
8/18/31
(144A)
‡
5,739,601
5,745,768
Sycamore
Tree
CLO
Ltd.
2024-5A
A2,
CME
Term
SOFR
3
Month
+
1.8000%,
6.0932%,
4/20/36
(144A)
‡
15,000,000
15,141,773
Sycamore
Tree
CLO
Ltd.
2023-3A
A1R,
CME
Term
SOFR
3
Month
+
1.6500%,
5.9432%,
4/20/37
(144A)
‡
140,000,000
141,005,130
Sycamore
Tree
CLO
Ltd.
2021-1A
AR,
CME
Term
SOFR
3
Month
+
1.3900%,
5.9012%,
1/20/38
(144A)
‡
31,000,000
31,242,339
Symphony
CLO
40
Ltd.
2023-40A
AR,
CME
Term
SOFR
3
Month
+
1.3100%,
5.7301%,
1/5/38
(144A)
‡
40,720,000
41,045,760
Symphony
CLO
45
Ltd.
2024-45A
A2,
CME
Term
SOFR
3
Month
+
1.5300%,
6.4033%,
10/15/37
(144A)
‡
10,000,000
10,083,122
Symphony
CLO
XXV
Ltd.
2021-25A
A,
CME
Term
SOFR
3
Month
+
1.2416%,
5.5348%,
4/19/34
(144A)
‡
124,724,000
124,908,192
Symphony
CLO
XXVIII
Ltd.
2021-28A
A,
CME
Term
SOFR
3
Month
+
1.4016%,
5.6919%,
10/23/34
(144A)
‡
23,100,000
23,134,576
Symphony
CLO
XXVIII
Ltd.
2021-28A
B,
CME
Term
SOFR
3
Month
+
1.9116%,
6.2020%,
10/23/34
(144A)
‡
13,750,000
13,807,192
Symphony
Loan
Funding
CLO
1
Ltd.
2024-1A
A1,
CME
Term
SOFR
3
Month
+
1.4300%,
5.7961%,
1/22/38
(144A)
‡
78,800,000
79,509,200
Symphony
Loan
Funding
CLO
1
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.6500%,
6.0161%,
1/22/38
(144A)
‡
12,000,000
12,011,558
TCI-Flatiron
CLO
Ltd.
2016-1A
AR3,
CME
Term
SOFR
3
Month
+
1.1000%,
5.4029%,
1/17/32
(144A)
‡
6,119,545
6,126,605
TCI-Symphony
CLO
Ltd.
2016-1A
AR2,
CME
Term
SOFR
3
Month
+
1.2816%,
5.5706%,
10/13/32
(144A)
‡
32,825,746
32,844,236
TCW
CLO
Ltd.
2022-1A
A1,
CME
Term
SOFR
3
Month
+
1.3400%,
5.6301%,
4/22/33
(144A)
‡
22,800,000
22,871,752
TCW
CLO
Ltd.
2024-1A
AJ,
CME
Term
SOFR
3
Month
+
1.8000%,
6.1076%,
1/16/37
(144A)
‡
12,000,000
12,101,246
TCW
CLO
Ltd.
2024-2A
A1,
CME
Term
SOFR
3
Month
+
1.4200%,
5.7229%,
7/17/37
(144A)
‡
10,000,000
10,085,974
Texas
Debt
Capital
CLO
2023-II
Ltd.
2023-2A
A1R,
CME
Term
SOFR
3
Month
+
1.3700%,
5.6632%,
10/21/37
(144A)
‡
53,000,000
53,341,553
Texas
Debt
Capital
CLO
Ltd.
2024-1A
A2,
CME
Term
SOFR
3
Month
+
1.7000%,
5.9901%,
4/22/37
(144A)
‡
16,000,000
16,155,251
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
18
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
THL
Credit
Wind
River
CLO
Ltd.
2018-2A
A1R,
CME
Term
SOFR
3
Month
+
1.2000%,
5.5020%,
7/15/30
(144A)
‡
$
12,808,991
$
12,831,714
THL
Credit
Wind
River
CLO
Ltd.
2019-3A
AR2,
CME
Term
SOFR
3
Month
+
1.0600%,
5.3620%,
4/15/31
(144A)
‡
34,110,008
34,188,963
THL
Credit
Wind
River
CLO
Ltd.
2019-1A
AR,
CME
Term
SOFR
3
Month
+
1.4216%,
5.7148%,
7/20/34
(144A)
‡
33,960,000
33,993,960
Thompson
Park
CLO
Ltd.
2021-1A
A1,
CME
Term
SOFR
3
Month
+
1.2616%,
5.5636%,
4/15/34
(144A)
‡
17,845,000
17,871,726
Tikehau
US
CLO
I
Ltd.
2021-1A
A2,
CME
Term
SOFR
3
Month
+
1.7116%,
6.0048%,
1/18/35
(144A)
‡
8,000,000
8,019,221
TRESTLES
CLO
III
Ltd.
2020-3A
A1R,
CME
Term
SOFR
3
Month
+
1.3900%,
5.6832%,
10/20/37
(144A)
‡
28,600,000
28,691,554
TRESTLES
CLO
Ltd.
2017-1A
A1RR,
CME
Term
SOFR
3
Month
+
1.4600%,
5.7601%,
7/25/37
(144A)
‡
20,250,000
20,427,096
Trinitas
CLO
VI
Ltd.
2017-6A
ARRR,
CME
Term
SOFR
3
Month
+
1.3300%,
5.6301%,
1/25/34
(144A)
‡
77,410,000
77,567,475
Trinitas
CLO
X
Ltd.
2019-10A
AR,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6820%,
1/15/35
(144A)
‡
21,700,000
21,710,108
Trinitas
CLO
XIX
Ltd.
2022-19A
A1R,
CME
Term
SOFR
3
Month
+
1.1100%,
5.4032%,
10/20/33
(144A)
‡
37,300,000
37,368,341
Trinitas
CLO
XXI
Ltd.
2022-21A
A,
CME
Term
SOFR
3
Month
+
2.3500%,
6.6432%,
1/20/36
(144A)
‡
43,000,000
43,217,279
Trinitas
CLO
XXXI
Ltd.
2024-31A
A1,
CME
Term
SOFR
3
Month
+
1.3500%,
5.7291%,
1/22/38
(144A)
‡
19,000,000
19,113,920
Trysail
CLO
Ltd.
2021-1A
A1,
CME
Term
SOFR
3
Month
+
1.3000%,
5.5901%,
7/20/32
(144A)
‡
89,531,030
89,561,569
Venture
28A
CLO
Ltd.
2017-28AA
A2R,
CME
Term
SOFR
3
Month
+
1.7116%,
6.0048%,
10/20/34
(144A)
‡
14,250,000
14,287,171
Venture
33
CLO
Ltd.
2018-33A
A1LR,
CME
Term
SOFR
3
Month
+
1.3216%,
5.6236%,
7/15/31
(144A)
‡
11,811,826
11,830,649
Venture
34
CLO
Ltd.
2018-34A
AR,
CME
Term
SOFR
3
Month
+
1.2800%,
5.5820%,
10/15/31
(144A)
‡
21,264,372
21,289,271
Venture
42
CLO
Ltd.
2021-42A
A2,
CME
Term
SOFR
3
Month
+
1.5616%,
5.8636%,
4/15/34
(144A)
‡
5,000,000
5,013,512
Venture
46
CLO
Ltd.
2022-46A
A1R,
CME
Term
SOFR
3
Month
+
1.4500%,
5.7432%,
10/20/37
(144A)
‡
8,000,000
8,061,002
Venture
XXX
CLO
Ltd.
2017-30A
A2,
CME
Term
SOFR
3
Month
+
1.6116%,
5.9136%,
1/15/31
(144A)
‡
15,500,000
15,546,968
Voya
CLO
Ltd.
2019-2A
AR,
CME
Term
SOFR
3
Month
+
1.2000%,
5.4932%,
7/20/32
(144A)
‡
28,159,068
28,221,702
Voya
CLO
Ltd.
2017-3A
A1R,
CME
Term
SOFR
3
Month
+
1.3016%,
5.5948%,
4/20/34
(144A)
‡
32,680,000
32,728,817
Voya
CLO
Ltd.
2021-1A
AR,
CME
Term
SOFR
3
Month
+
1.0000%,
0.0000%,
7/15/34
(144A)
†,‡
85,000,000
84,940,500
Voya
CLO
Ltd.
2020-1A
AR,
CME
Term
SOFR
3
Month
+
1.4116%,
5.7192%,
7/16/34
(144A)
‡
60,576,000
60,678,071
Voya
CLO
Ltd.
2022-4A
A1R,
CME
Term
SOFR
3
Month
+
1.5100%,
5.8032%,
4/20/37
(144A)
‡
35,500,000
35,721,186
Voya
CLO
Ltd.
2018-4A
A1RR,
CME
Term
SOFR
3
Month
+
1.3600%,
5.6620%,
10/15/37
(144A)
‡
30,000,000
30,204,585
Voya
CLO
Ltd.
2020-3A
ARR,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5432%,
1/20/38
(144A)
‡
25,000,000
25,187,500
Voya
CLO
Ltd.
2020-2A
A1RR,
CME
Term
SOFR
3
Month
+
1.3100%,
5.5904%,
1/20/38
(144A)
‡
85,000,000
85,783,700
Janus
Henderson
AAA
CLO
ETF
Schedule
of
Investments
(unaudited)
January
31,
2025
19
Shares/
Principal
Amounts
Value
Collateralized
Loan
Obligations
-
(continued)
Voya
Ltd.
2024-3A
A2,
CME
Term
SOFR
3
Month
+
1.5800%,
5.8732%,
7/20/37
(144A)
‡
$
12,000,000
$
12,099,412
Whitebox
CLO
II
Ltd.
2020-2A
A1R2,
CME
Term
SOFR
3
Month
+
1.3800%,
5.6766%,
10/24/37
(144A)
‡
30,000,000
30,240,000
Whitebox
CLO
IV
Ltd.
2023-4A
A1,
CME
Term
SOFR
3
Month
+
2.1500%,
6.4432%,
4/20/36
(144A)
‡
10,000,000
10,046,104
Whitebox
CLO
IV
Ltd.
2023-4A
A2,
CME
Term
SOFR
3
Month
+
2.3000%,
6.5932%,
4/20/36
(144A)
‡
20,000,000
20,009,646
Wind
River
CLO
Ltd.
2022-1A
AR,
CME
Term
SOFR
3
Month
+
1.3500%,
5.6432%,
7/20/35
(144A)
‡
53,000,000
53,125,785
Wind
River
CLO
Ltd.
2024-1A
A,
CME
Term
SOFR
3
Month
+
1.6000%,
5.8932%,
4/20/37
(144A)
‡
135,000,000
135,999,149
Zais
CLO
11
Ltd.
2018-11A
A1R,
CME
Term
SOFR
3
Month
+
1.2500%,
5.5432%,
1/20/32
(144A)
‡
51,847,110
51,871,867
Zais
CLO
11
Ltd.
2018-11A
BR,
CME
Term
SOFR
3
Month
+
1.7900%,
6.0832%,
1/20/32
(144A)
‡
31,600,000
31,662,619
Zais
CLO
18
Ltd.
2022-18A
A1A,
CME
Term
SOFR
3
Month
+
1.5200%,
5.8201%,
1/25/35
(144A)
‡
46,875,000
46,944,281
Total
Collateralized
Loan
Obligations
(cost
$21,131,241,164)
21,210,348,695
Total
Investments
(total
cost
$
21,131,241,164
)
-
106
.1
%
21,210,348,695
Liabilities,
net
of
Cash,
Receivables
and
Other
Assets
-
(6.1%)
(1,214,390,765)
Net
Assets
-
100.0%
$19,995,957,930
Summary
of
Investments
by
Country
-
(Long
Positions)
(unaudited)
Country
Value
%
of
Investment
Securities
United
States
$
21,210,348,695
100
.0
%
Schedule
of
Affiliated
Investments
-
(%
of
Net
Assets)
Affiliated
Investments,
at
Value
at
10/31/24
Purchases
Sales
Proceeds
Realized
Gain/
(Loss)
Change
in
Unrealized
Appreciatio
n/
(Depreciation)
Affiliated
Investments,
at
Value
at
1/31/25
.............
Shares
Held
at
1/31/25
Dividend
Income
Investment
Company
-
N/A
Money
Market
Funds
-
N/A
Janus
Henderson
Cash
Liquidity
Fund
LLC,
4.3414%
∞
$
–
$
2,862,942,887
$
(
2,862,942,887
)
$
–
$
–
$
–
–
$
2,086,177
Janus
Henderson
AAA
CLO
ETF
Notes
to
Schedule
of
Investments
and
Other
Information
(unaudited)
January
31,
2025
20
CME
Chicago
Mercantile
Exchange
LLC
Limited
Liability
Company
SOFR
Secured
Overnight
Financing
Rate
∞
Rate
shown
is
the
7-day
yield
as
of
January
31,
2025.
†
The
position
has
not
yet
settled
as
of
January
31,
2025.
The
coupon
rate
is
undetermined.
‡
Variable
or
floating
rate
security.
Rate
shown
is
the
current
rate
as
of
January
31,
2025.
Certain
variable
rate
securities
are
not
based
on
a
published
reference
rate
and
spread;
they
are
determined
by
the
issuer
or
agent
and
current
market
conditions.
Reference
rate
is
as
of
reset
date
and
may
vary
by
security,
which
may
not
indicate
a
reference
rate
and/or
spread
in
their
description.
144A
Securities
sold
under
Rule
144A
of
the
Securities
Act
of
1933,
as
amended,
are
subject
to
legal
and/or
contractual
restrictions
on
resale
and
may
not
be
publicly
sold
without
registration
under
the
1933
Act.
Unless
otherwise
noted,
these
securities
have
been
determined
to
be
liquid
in
accordance
with
the
requirements
of
Rule
22e-4,
under
the
1940
Act.
The
total
value
of
144A
securities
as
of
the
period
ended
January
31,
2025
is
$21,210,348,695
which
represents
106.1%
of
net
assets.
The
following
is
a
summary
of
the
inputs
that
were
used
to
value
the
Fund's
investments
in
securities
and
other
financial
instruments
as
of
January
31,
2025
.
See
Notes
to
Financial
Statements
for
more
information.
Valuation
Inputs
Summary
Level
1
-
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
Investments
in
Securities:
Collateralized
Loan
Obligations
$
—
$
21,210,348,695
$
—
$
21,210,348,695
Total
Assets
$
—
$
21,210,348,695
$
—
$
21,210,348,695
Janus
Henderson
AAA
CLO
ETF
21
Investment
Valuation 
Fund holdings
are
valued
in
accordance
with
policies
and
procedures
established
by
the
Adviser
pursuant
to
Rule
2a-5
under
the
1940
Act
and
approved
by
and
subject
to
the
oversight
of
the
Trustees
(the
“Valuation
Procedures”).
Equity
securities,
including
shares
of
exchange-traded
funds,
traded
on
a
domestic
securities
exchange
are
generally
valued
at
readily
available
market
quotations,
which
are
(i)
the
official
close
prices
or
(ii)
last
sale
prices
on
the
primary
market
or
exchange
in
which
the
securities
trade.
If
such
price
is
lacking
for
the
trading
period
immediately
preceding
the
time
of
determination,
such
securities
are
generally
valued
at
their
current
bid
price.
Equity
securities
that
are
traded
on
a
foreign
exchange
are
generally
valued
at
the
closing
prices
on
such
markets.
In
the
event
that
there
is
no
current
trading
volume
on
a
particular
security
in
such
foreign
exchange,
the
bid
price
from
the
primary
exchange
is
generally
used
to
value
the
security.
Foreign
securities
and
currencies
are
converted
to
U.S.
dollars
using
the
current
spot
USD
dollar
exchange
rate
in
effect
at
the
close
of
the
London
Stock
Exchange.
The Fund will
determine
the
market
value
of
individual
securities
held
by
it
by
using
prices
provided
by
one
or
more
approved
professional
pricing
services
or,
as
needed,
by
obtaining
market
quotations
from
independent
broker-dealers.
Most
debt
securities
are
valued
in
accordance
with
the
evaluated
bid
price
supplied
by
the
Adviser-approved
pricing
service
that
is
intended
to
reflect
market
value.
The
evaluated
bid
price
supplied
by
the
pricing
service
is
an
evaluation
that
may
consider
factors
such
as
security
prices,
yields,
maturities
and
ratings.
Certain
short-term
securities
maturing
within
60
days
or
less
may
be
evaluated
and
valued
on
an
amortized
cost
basis
provided
that
the
amortized
cost
determined
approximates
market
value.
Securities
for
which
market
quotations
or
evaluated
prices
are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
determined
in
good
faith
by
the
Adviser
pursuant
to
the
Valuation
Procedures. Circumstances
in
which
fair
valuation
may
be
utilized
include,
but
are
not
limited
to:
(i)
a
significant
event
that
may
affect
the
securities
of
a
single
issuer,
such
as
a
merger,
bankruptcy,
or
significant
issuer-specific
development;
(ii)
an
event
that
may
affect
an
entire
market,
such
as
a
natural
disaster
or
significant
governmental
action;
(iii)
a
nonsignificant
event
such
as
a
market
closing
early
or
not
opening,
or
a
security
trading
halt;
and
(iv)
pricing
of
a
non-valued
security
and
a
restricted
or
nonpublic
security.
Special
valuation
considerations
may
apply
with
respect
to
“odd-lot”
fixed-income
transactions
which,
due
to
their
small
size,
may
receive
evaluated
prices
by
pricing
services
which
reflect
a
large
block
trade
and
not
what
actually
could
be
obtained
for
the
odd-
lot
position.
The
value
of
the
securities
of
mutual
funds
held
by
the
Fund,
if
any,
will
be
calculated
using
the
NAV
of
such
mutual
funds,
and
the
prospectuses
for
such
mutual
funds
explain
the
circumstances
under
which
they
use
fair
valuation
and
the
effects
of
using
fair
valuation.
The
value
of
the
securities
of
any
cash
management
pooled
investment
vehicles
that
operate
as
money
market
funds
held
by
the
Fund,
if
any,
will
be
calculated
using
the
NAV
of
such
funds.
Valuation
Inputs
Summary 
FASB
ASC
820,
Fair
Value
Measurements
and
Disclosures
(“ASC
820”),
defines
fair
value,
establishes
a
framework
for
measuring
fair
value,
and
expands
disclosure
requirements
regarding
fair
value
measurements.
This
standard
emphasizes
that
fair
value
is
a
market-based
measurement
that
should
be
determined
based
on
the
assumptions
that
market
participants
would
use
in
pricing
an
asset
or
liability
and
establishes
a
hierarchy
that
prioritizes
inputs
to
valuation
techniques
used
to
measure
fair
value.
These
inputs
are
summarized
into
three
broad
levels: 
Level
1
–
Unadjusted
quoted
prices
in
active
markets
the
Fund
has
the
ability
to
access
for
identical
assets
or
liabilities.
Level
2
–
Observable
inputs
other
than
unadjusted
quoted
prices
included
in
Level
1
that
are
observable
for
the
asset
or
liability
either
directly
or
indirectly.
These
inputs
may
include
quoted
prices
for
the
identical
instrument
on
an
inactive
market,
prices
for
similar
instruments,
interest
rates,
prepayment
speeds,
credit
risk,
yield
curves,
default
rates
and
similar
data.
Assets
or
liabilities
categorized
as
Level
2
in
the
hierarchy
generally
include:
debt
securities
fair
valued
in
accordance
with
the
evaluated
bid
or
ask
prices
supplied
by
a
pricing
service;
securities
traded
on
OTC
markets
and
listed
securities
for
which
no
sales
are
reported
that
are
fair
valued
at
the
latest
bid
price
(or
yield
equivalent
thereof)
obtained
from
one
or
more
dealers
transacting
in
a
market
for
such
securities
or
by
a
pricing
service
approved
by
the
Fund’s
Trustees;
and
certain
short-term
debt
securities
with
maturities
of
60
days
or
less
that
are
fair
valued
at
amortized
cost.
Other
securities
that
may
be
categorized
as
Level
2
in
the
hierarchy
include,
but
are
not
limited
to,
preferred
stocks,
bank
loans,
swaps,
investments
in
unregistered
investment
companies,
options,
and
forward
contracts.
Level
3
–
Unobservable
inputs
for
the
asset
or
liability
to
the
extent
that
relevant
observable
inputs
are
not
available,
representing
the
Fund’s
own
assumptions
about
the
assumptions
that
a
market
participant
would
use
in
valuing
the
asset
or
liability,
and
that
would
be
based
on
the
best
information
available.
Janus
Henderson
AAA
CLO
ETF
22
The
inputs
or
methodology
used
for
fair
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
The
summary
of
inputs
used
as
of
January
31,
2025 to
fair
value
the
Fund’s
investments
in
securities
and
other
financial
instruments
is
included
in
the
“Valuation
Inputs
Summary”
in
the
Notes
to
Schedule
of
Investments
and
Other
Information.
For
additional
information
on
the
Fund,
please
refer
to
the
Fund's
most
recent
semiannual
or
annual
financial
statements.
125-25-70351
03-25